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ABSTRACT 
 
The marketing of infant feeding products is almost impossible as the infant nutrition 
industry is highly regulated. Despite operating under strict regulations, the infant 
formula manufacturing companies still generate high revenues on an annual basis.   
 
The infant formula manufacturing industry operates under a value chain which can 
be broken down into six sequential steps.  These steps are: (1) Translational 
science; (2) Product development; (3) Clinical research; (4) Product notification; (5) 
Reimbursement granting and (6) Product marketing. Medical nutrition companies 
aspire to understand product requirements of healthcare professionals and medical 
representatives. This is to enable direct investment to acquire market share without 
wasting resources. The medical nutrition industry currently makes use of medical 
representatives to execute product marketing. Manufacturing companies invest a lot 
of money into developing their products, employing and training medical 
representatives and trust that this will be enough to persuade healthcare 
professionals to recommend their products to parents. This study analyses the main 
contributing factors that enhance prescription of specialised infant formula by 
healthcare professionals.   
 
This study was conducted in a positivistic paradigm by making use of a quantitative 
approach. Healthcare professionals from Port Elizabeth, working with paediatric 
patients were included in this study.  The healthcare professionals were chosen by a 
convenience sampling method and were then interviewed.  The empirical interview 
results were substantiated with the interpretive findings which were in the form of 
verbatim statements extracted directly from the research questionnaire. Linkage 
between the dependable variable (prescription) and independent variables 
(manufacturing company; product composition; cost of product; medical 
representative and peers) were established and analysed.   
 
The research revealed that prescription behaviour is an important construct which 
can be measured in medical practices. Prescription behaviour is correlated with 
positive business and medical outcomes and manufacturing companies are able to 
exert influence over it through the identified variables.  Of these variables, efficacy of 
vii 
 
a product, trusted manufacturing company and the medical representatives were 
found to have direct and significant effects. Healthcare professionals tend to 
prescribe a specialised infant formula if they have seen results and trust the outcome 
of the product. It is advisable for manufacturing companies to exert great effort 
before appointing a medical representative, to make sure that the right candidate 
represents the face of the company.   
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Chapter 1 
INTRODUCTION AND BACKGROUND TO THE STUDY 
 
1.1 INTRODUCTION 
 
1.1.1 Marketing of infant formula 
 
The marketing of infant feeding products is almost impossible as the infant nutrition 
industry is highly regulated.  With the World Health Organisation’s (WHO) stringent 
regulatory protocols it limits the scope for marketing infant nutrition products.  In 
1981, the WHO established The International Code of Marketing of Breast-milk 
Substitutes.   The purpose of this code is to reassure safe and sufficient nutrition for 
infants by protecting and promoting breastfeeding and by advocating the use of 
breast-milk substitutes only if necessary. The code regulates the marketing and 
distribution industry of infant formula manufacturing companies to protect vulnerable 
consumers.  The code recognises that some mothers may not be able to breastfeed 
or do so only partially and that in these instances there is a justifiable market for 
infant formula and that infant formula should be made available through commercial 
distribution systems.  The marketing and distribution of infant formula may not 
interfere with the protection and promotion of breastfeeding.  Breast-milk substitutes, 
i.e. infant formula should be available when needed but should not be promoted 
(WHO, 1981).   
 
A study completed by Yee and Chin (2007) found that parents are very quality 
orientated and consider quality and brand when deciding on an infant formula.  
Claims from manufacturers regarding specific health benefits and the medical 
conditions of their child are also significant reasons that influence their decision 
(Sowden, Marais and Beukes, 2009). In response to protect consumers from health 
claims made by pharmaceutical companies, the South African Department of Health 
published the Regulations Relating to Foodstuffs for Infants and Young Children 
R991 on 6 December 2012. The regulations aim to control the labelling (health 
claims), composition, packaging, manufacturing, sale and promotion of infant formula 
(Tshikovhi, Gericke and Becker, 2015). 
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The following is an extract of R991 that reiterates the researcher’s argument: 
“(a) sale devices such as rebates, benefits in kind, kickbacks or any other pecuniary 
advantages, special displays to promote sales, advertisements about the availability 
of the product at a specific retail outlet and the price of the product, tie-in sales, 
discounts in any form, competitions with prizes, or any other incentives and gifts;  
(b) direct or indirect contact between company personnel and members of the public 
in furtherance of or for the purpose of promoting the business of the company with 
regard to the products.  For purposes of these regulations indirect contact 
specifically includes internet sites hosted on behalf of a South African entity or an 
entity that does business in South Africa, television and radio, telephone or Internet 
help lines and mother and baby clubs but excludes contact in regards to product 
quality complaints and adverse events;    
(c) the distribution of any information or educational material on the nutrition or 
feeding of infants and young children;   
(d) promotional items such as stationery, T-shirts or other items of clothing, 
headgear, household utensils, and household linens that refer to products; and  
(e) the brand name of a product are not allowed to be used at any event for the 
general public; and  
(f) advertisements in written publications, television, radio, film, electronic media, 
email, video, telephone displays, exhibitions and outdoor advertisements such as 
billboards, posters, signs and electronic signs” (Mills, 2014. pp.259-260).  
 
An infant formula manufacturing company is not allowed to endorse products in an 
indirect manner by endorsing research bursaries, financial support for equipment or 
sponsorship, unless prior authorisation has been attained from the  Director-General 
of the Department of Health. Sales encouragement or advertisement through 
healthcare professionals or health establishments of products competing with breast-
milk are prohibited.  A private pharmacy or commercial outlet may sell infant formula, 
but has to abstain from promoting or advertising in any way. Only healthcare 
professionals are allowed to speak to parents directly with regards to deciding on a 
suitable infant formula for their infant. Employees working for infant formula 
manufacturing company or commercial workers are strictly forbidden as well (Mills, 
2014). The stringent codes of the WHO and R991 confine the infant formula 
companies to develop innovative marketing strategies.   
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1.1.2 Clarification of concepts and terms 
 
Amino-based formula is suitable for the dietary management of CMPA, “multiple food 
protein intolerance and other conditions. These formulas are based on 100% free 
amino acids and do not contain any cow’s milk protein to reduce the possibility of a 
food allergic reaction,” (Owens, Labuschagne and Lombard, 2012. p.29). 
 
Common symptoms of food allergy: include skin rashes, itching, abdominal pain, 
vomiting and diarrhoea (Rolfes, Pinna and Whitney, 2006). 
 
Cow’s Milk Protein Allergy (CMPA):  This allergy is defined as hypersensitivity to the 
protein found in cow’s milk (Rolfes, et al., 2006). 
 
Extensively hydrolysated cow’s milk formulas:  means the cow’s milk protein in the 
formula has been extensively broken down to a certain degree and molecule size 
(Owens, et al., 2012). 
 
Food allergy (hypersensitivity):  “A food allergy occurs when a food component, 
usually an incomplete digested protein strand, is absorbed into the blood and elicits 
an immune response.  The allergen is treated as a foreign particle that needs to be 
neutralized and allergen-specific antibodies are produced to mount a defence,” 
(Rolfes, et al., 2006. p.765). 
 
Healthcare Professionals (HCP) “a person given legal authority to make medical 
decisions for another in the event of incapacitation,” (Rolfes, et al., 2006. p.690). 
 
Hypoallergenic formulas: “clinically tested infant formulas that do not provoke 
reactions in 90% of infants or children with confirmed cow’s milk protein allergy.  Like 
all infants, hypoallergenic formulas must demonstrate nutritional suitability to support 
infant growth and development. Extensively hydrolysed and free amino-acid based 
formulas are examples,” (Rolfes, et al., 2006. p.516). 
 
Infant can be defined as a human child 0 – 12 months of age (Rolfes, et al., 2006). 
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Infant Formula (IF) or standardised cow’s milk formula: “Infant formula is a product 
based on cow’s milk proven to be suitable for infant feeding. The nutritional safety 
and adequacy of infant formula should be scientifically demonstrated to support 
normal growth and development of infants,” (Koletzko, et al., 2005. p.586).  
 
A Medical Representative’s (MR) role is to detail a range of products in assigned 
territory. In addition they are to develop partnerships with healthcare professionals 
through efficient communication and support activities that adhere to the WHO code 
and R991 legislation.  A medical representative is better known to the public as a 
‘sales rep’. 
 
R991 Regulations “are designed to remove commercial pressures from the infant 
feeding arena, to ensure that all parents receive independent and objective 
information and to ensure that all mothers who wish to breastfeed are supported to 
do so,” (Mills, 2014. p.257). 
 
Specialised infant formulas: “Standard formulas are inappropriate for some infants.  
Special formulas have been designed to meet the dietary needs of infants with 
specific conditions such as prematurity or inherited diseases. Infants allergic to cow’s 
milk protein can tolerate special hypoallergenic formulas or formulas based on soy 
protein,” (Rolfes, et al., 2006. p.516). 
 
WHO code: “The International Code of Marketing of Breast-milk Substitutes is an 
international health policy framework for breastfeeding promotion adopted by the 
World Health Assembly (WHA) of the World Health Organisation (WHO) in 1981,” 
(WHO, 1981. p.5). 
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1.2 BACKGROUND TO THE STUDY 
 
Breast-milk is potentially the best source of nutrition for an infant, however in certain 
cases women may be advised not to breastfeed and rather use specially formulated 
milk. These cases include: 
 The use of certain medications.  
 The presence of a specific illness.  
 Infants who have a metabolic disorder or are allergic to mother’s breast-milk. 
 
There are various reasons that support the necessity of an IF on the market.  The 
industry still generates high revenues on an annual basis, despite operating under 
such strict regulations.   
 
The medical nutrition industry needs to abide by the European Society for Paediatric 
Gastroenterology Hepatology and Nutrition (ESPGHAN) guideline for product 
development.  This industry operates under a value chain which can be broken down 
into six sequential steps.  These steps are: (1) Translational science; (2) Product 
development; (3) Clinical research; (4) Product notification; (5) Reimbursement 
granting and (6) Product marketing. By managing the value chain, companies drive 
ideas from the concept phase to the end of the product lifecycle. This approach 
requires the translation of nutrition science through food and ingredient technology to 
generate innovative impactful products of high quality, stability, safety and value for 
consumers (Weenen, Pronker, Commandeur and Claassen, 2013). South Africa also 
abides by the ESPGHAN guidelines.   
 
Medical nutrition companies aspire to understand product requirements of healthcare 
professionals and medical representatives. This is to enable direct investment to 
acquire market share without wasting resources. The primary customer is the HCP 
prescribing the IF (Bassi, 2013). The medical nutrition industries currently make use 
of MRs to execute step 6, which is product marketing.  The role of a MR is to detail 
the features and benefits of a specific product to a HCP with the aim to persuade the 
HCP to recommend the product to parents.  Literature revealed that a HCP will 
prescribe a product if it is manufactured by a reputable company, abides by 
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ESPGHAN guidelines, is tested in trials and the results have been published in 
trusted scientific sources. The product must be locally available, cost effective and 
the right product for the specific individual (Koletzko, et al., 2005).  IF manufacturing 
companies aspire to abide to the preferences of the HCP’s at all cost for the promise 
of their recommendation.   
 
This study focused only on specialised infant formula indicated for cow’s milk protein 
allergy (CMPA). CMPA is the most common single allergy in infants.  Prevalence of 
this allergy is about 2.5% in the first three years of life.  Breast-milk, the infant’s best 
source of nutrition and protection against atopic diseases, is the preferred food for all 
infants.  When the use of breast-milk is not possible, extensively hydrolysated cow’s 
milk formulas are preferred alternatives to standard cow’s milk formulas.  If 
symptoms continue, an amino-based formula may be offered. The American 
Academy of Paediatrics recommends the use of breast-milk, casein or whey protein 
hydrolysates with peptides having a molecular weight of less than 1200 Daltons for 
infants with clinical symptoms of CMPA (Hubbard, 2004).  This will be explained in 
more depth in Chapter 2 by the use of secondary data.    
 
1.3  PROBLEM STATEMENT 
 
1.3.1 Main problem 
 
Manufacturing companies invest a lot of money in developing their products, 
employing and training MRs and trust that this will be enough to persuade HCPs to 
recommend their products to parents.   
 
The ESPGHAN, in alliance with its sister societies in the global Federation of 
International Societies on Paediatric Gastroenterology, Hepatology and Nutrition 
(FISPGHAN), suggests minimum and maximum values of nutrient contents in IF.  
The ultimate intention is to offer safe and nutritionally sufficient IF products that meet 
the nutritional requirements of healthy infants (Koletzko, et al., 2005). Does this strict 
guideline not make all infant formulas essentially the same?   
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The sale of IF products depend predominantly on the recommendations of HCPs.  
The researcher agreed with Owens, et al. (2012) that all IFs are nutritionally 
interchangeable, because they are obliged to contain sufficient amounts of basic 
nutrients to be classified as breast-milk substitute. No evidence exists to recommend 
one brand above another. Based on this statement, how do HCPs then decide which 
IF to recommend?   
 
Manufacturing companies are not allowed to market IF directly because of the strict 
regulations.  MRs are the face of the company and can only share scientific 
information with HCPs. How effective is this strategy? If strict guidelines result in all 
IFs to be almost exactly the same, what really are the contributing factors that 
enhance prescription of HCPs? 
 
From the arguments made above the following main research question (RQM) is 
developed: 
 
Can a marketing model be developed to enhance healthcare professionals’ 
prescription for specialised infant formula? 
 
1.3.2 Sub-questions 
 
To allow for the development of the marketing framework, the following sub-
questions were identified: 
 
 Sub-question one 
What do literature studies define as key factors influencing healthcare professionals 
prescribing behaviour?   
 
 Sub-question two 
How can the prescribing behaviour of healthcare professionals be measured, 
according to the literature? 
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 Sub-question three 
What are the key factors regarding a product that will persuade a healthcare 
professional to prescribe the product? 
 
 Sub-question four 
How can a medical representative add maximum value to a healthcare professionals 
practice? 
 
 Sub-question five 
What do literature studies reveal as the main factors that influence the end consumer 
in purchasing the product? 
 
 Sub-question six 
Can a detailed research methodology be developed to test the hypothesised model, 
to assist in understanding and to allow replication of the study? 
 
1.4 PURPOSE OF THE STUDY 
 
The study aimed to fill a gap to address the paucity in research with regards to the 
prescribing habits of healthcare professionals, with particular focus on CMPA.  This 
study aimed to provide guidance to manufacturing companies that focus on 
developing products for specialised conditions and to stimulate them to devise 
product development and marketing strategies to enhance their competitive 
advantage. These strategies can aid manufacturing companies to: 
 
 Save money by focussing on the core features in the development of 
specialised IF. 
 Focus on the key contributing features of the product to improve the condition, 
therefore result in a superior quality product for the end consumer. 
 Save money by not investing in unnecessary marketing strategies. 
 MRs will be effective in detailing specialised products to HCPs, therefore 
adding value to their practice.   
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1.5 RESEARCH OBJECTIVES 
 
1.5.1 Primary research objective 
 
To develop a marketing framework to enhance healthcare professionals' prescription 
for specialised infant formula. 
 
1.5.2 Secondary research objectives 
 
To give cause to the primary objective of this study, the following secondary 
research objectives were formulated: 
 
 Conduct a thorough literature review and to review secondary data to evaluate 
current personal selling techniques.   
 
 To conduct a quantitative study by means of a structured questionnaire with 
HCPs to determine the persuading factors in a specialised IF; to evaluate 
what the HCPs perceive as important in a specialised product; to evaluate the 
importance of the manufacturing company, cost and availability, as well as to 
determine the roles of the MR and peers in the prescribing practice of HCPs. 
 
 To establish how prescribing habits of HCPs can be measured. 
 
 To collect and analyse primary data; deliver relevant conclusions and 
recommendations based on the findings of the questionnaires of the HCPs; 
and determine the effectiveness of manufacturing companies in enhancing 
HCPs’ prescriptions for specialised infant formula, by the MR detailing the 
products to the HCP. 
 
1.6 LITERATURE REVIEW 
 
Primary and secondary research was conducted to achieve the objectives of this 
research. A questionnaire was formulated after the literature review.  
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1.6.1 Secondary research 
 
Under the restriction of World Health Organisation (WHO) Code, infant formula 
companies cannot promote their products through the mass media and any other 
direct promotion channels in order to protect breast-feeding for new born babies. The 
infant formula industry must rely on the prescription or recommendation from the 
HCPs in general hospitals and/or clinics.  The HCPs in hospitals become the opinion 
leaders in word-of-mouth marketing for the mothers, the purchasing decision-
makers.  It is the most important activity to call on the HCPs in hospitals to establish 
an understanding relationship and promote the infant formula by the MR, who have a 
background in nutrition, pharmacy, or nursing (Lin, Liao and Tseng. 2011).  
Therefore, the MRs understanding of HCPs needs and reasoning for prescribing 
specialised infant formula becomes a critical issue in infant formula companies. 
 
A comprehensive literature study was conducted to analyse the specialised IF 
industry and to understand HCPs needs and preferences for prescribing specialised 
infant formula.  It serves to determine what the key selling techniques of personal 
selling to assemble preferred techniques for MR.   
 
International and national data searches were conducted at the library of the Nelson 
Mandela Metropolitan University.  The following resources were used for this 
treatise:  
 Physical journals. 
 E-journals. 
 The Internet. 
 Books. 
 
As far as can be established, no similar research studies have been conducted in 
South Africa.  
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1.6.2 Primary research 
 
The secondary research was used to construct a comprehensive theoretical model 
identifying the main factors influencing HCP prescribing habits.  
 
In the context of this topic, a lot of research has been done to analyse and to 
understand the factors which influence HCP prescribing decisions and practice. The 
related literature suggests several factors that may have a role in influencing the 
prescribing behaviour of HCPs.  Some factors are fixed and they do not offer any 
opportunity for modification and improvements in prescribing behaviour.  Such 
factors for instance include, the age and sex of the HCP or the patient, the socio-
economic characteristics of the practicing area or the reimbursement status of 
therapy.  On the other hand, there are factors which can be influenced and in turn 
cause a modification to the prescribing behaviour of HCPs.  Such factors may be the 
under and post graduate education and the experience of the HCP, various social 
factors, and the number of practitioners in a practice.  More specifically, it reveals the 
criteria which justify prescription choice, the sources of HCP information, the 
attitudes towards specialised infant formula, the importance of the financial 
implications of decision, etcetera. This information can help companies to identify the 
measures needed to improve the effectiveness of MRs personal selling skills and 
consequently it can contribute towards a greater economic and clinical efficiency of 
the use of specialised infant formula.   
 
Research done by Theodorou, et al (2009), Maynor (2010) and Koletzko, et al (2005) 
disclose that clinical effectiveness is the most important factor considered by HCPs 
when they prescribe pharmaceutical drugs.  Consistent data from various studies 
reveals that pharmaceutical sales representatives, medical cost, patient medical aid 
coverage, drug price and peers of HCP are important factors influencing prescribing 
decision.   Literature also revealed that a HCP will prescribe a product if it is 
manufactured by a reputable company, abides by ESPGHAN guidelines, is tested in 
trials and the results have been published in trusted scientific sources, locally 
available, and the right product for the specific individual.  The theoretical model to 
identify the main factors influencing HCP prescribing habits was developed after 
analysing the secondary research.   
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A positivism research paradigm was adopted and the theoretical model was tested 
by means of exploratory research.  
 
1.7 SCOPE OF THE STUDY 
 
This study only included HCPs from the following professions: dieticians, 
paediatricians and private nurses for two reasons. Firstly, these professionals are the 
primary HCPs who end users consult for advice regarding infant feeding and 
secondly, the researcher had access to these professionals for honest and effective 
feedback. The geographical scope of this research only included HCPs from the 
Nelson Mandela Bay, Port Elizabeth, in the Eastern Cape region. 
 
1.8 RESEARCH DESIGN AND HYPOTHESISED CONCEPTUAL MODEL 
 
In this section a broad overview of the research design is provided.  A detailed 
review of the methodology adopted follows in Chapter 3. 
 
1.8.1 Research paradigm 
 
Collis and Hussey (2014) state that a research paradigm is a philosophical 
framework that steers how scientific research should be performed (Collis and 
Hussey, 2014).  There are two main paradigms: the positivist approach and the 
interpretivism approach. The positivist approach is based on the principle that reality 
is independent, and the objective is the discovery of theories, based on empirical 
research (observation and experiment).  ‘Positive information’ is a great source of 
knowledge, because every assertion can be scientifically verified and it is possible to 
provide a logical or mathematical explanation. It is believed that every statement can 
be measured, therefore positivism is associated with quantitative methods of 
analysis based on the statistical analysis of quantitative research data (Yin, 2011; 
Collin and Hussey, 2014). 
 
Interpretivism is based on the principle that ‘social reality’ is not objective but greatly 
subjective because it is formed by our views. The interpretivism paradigm allows the 
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researcher to interact with what is being researched, and is therefore highly 
subjective because it is impractical to think that the researcher does not have an 
influence on the phenomenon being investigated (Yin, 2011; Collin and Hussey, 
2014). 
 
The positivist approach focuses on quantifying social phenomenon, interpretivism 
focuses on investigating the intricacy of social phenomenon with the purpose of 
attaining an interpretive understanding. Interpretivism applies a variety of methods 
that aspire to describe, interpret and understand the phenomena under investigation.  
Therefore interpretive research findings not derived from the statistical analysis of 
qualitative data, but are derived from the interpretation and analysis of qualitative 
data (Collin and Hussey, 2014).  
 
The results of this study can be measured and interpreted through statistical 
analysis.  Every statement can be scientifically verified and is possible to provide a 
logical explanation.  Therefore is this a quantitative study conducted in a positivistic 
paradigm.   
 
1.8.2 Data collection 
 
The researcher used primary and secondary data. Primary data is data collected 
from an existing source, such as internal records, databases and publications. 
Primary data for this study was collected via a literature review. Secondary data is 
generated from an original source, such as interviews, surveys, focus groups or your 
own experiments.  The collection of secondary data required decisions to be made 
regarding the population, sample frame and sample. These concepts will be defined 
in Chapter 3.  The researcher collected secondary data for this study through 
interviewing HCPs in the assigned territory by making use of a set questionnaire.   
 
A sampling frame is a testimony of the population from which a sample can be 
drawn. Population is defined as a body of people under consideration and a sample 
is a subset of the population. This study is under the positivistic paradigm, therefore 
the research data was analysed through the use of descriptive statistics to interpret 
the prescribing behaviour of healthcare professionals working with paediatric 
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patients in Port Elizabeth.  The researcher had little influence on the availability of 
the participants in the sample, therefore this sample was classified as a convenience 
sample.   Strategic research questions were developed to facilitate the interviews 
with HCPs to collect secondary data.   
       
1.8.3 Data gathering 
 
The importance of quantitative data is on the quality and the depth of the data 
collected about a phenomenon (Collin and Hussey, 2014).  Therefore, the aim of the 
researcher was to collect detailed and meaningful rich data. This was completed 
through interviews with various HCPs by making use of a constructed questionnaire.   
 
1.8.4 Research methodology 
 
This is a quantitative study done in a positivistic paradigm.  The researcher made 
use of a structured research instrument with Likert type statements.  The healthcare 
professionals working with specialised infant formula in Port Elizabeth, were 
analysed.  The results of this study, discussed in chapter 4, propose a framework 
which could be generally applied to the healthcare professionals’ community 
throughout South Africa.   
 
Research findings were derived from quantitative methods of analysis, which are 
based on the interpretation of quantitative research data. Clear justification for the 
selection of the particular methodology will be given in Chapter 3.   
 
The following process was followed to address the main problem and the sub-
questions as previously discussed: 
 
Step 1 A literature review was conducted: to determine the nature of MRs’ 
personal selling techniques to persuade HCPs’ prescriptions; to identify 
key general influencers and to highlight contributing factors.   
 
Step 2 Literature was further reviewed for measurement instruments of HCPs’ 
prescribing habits. 
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Step 3 A hypotheses was developed from the literature review and was used 
to aid the researcher in the construction of a hypothesised model. 
 
Step 4 A comprehensive research questionnaire was constructed and used as 
an interview guide to determine the most relevant influencing factors of 
HCPs’ prescribing habits. 
 
Step 5 Empirical data was acquired by conducting face-to-face interviews. 
 
Step 6 Results were captured by using Microsoft Excel. The researcher 
analysed and interpreted the data.   
 
1.8.5 The hypotheses and foundation for the conceptual model 
 
The following null and alternative hypotheses were formulated to assist in attaining 
the above mentioned primary and secondary research objectives for testing with 
empirical research: 
 
H01 = Manufacturing companies exert no influence on prescribing habits 
HA1 = Manufacturing companies influence prescribing habits 
 
H02 = Product efficacy exerts no influence on prescribing habits 
HA2 = Product efficacy influences prescribing habits 
 
H03 = Cost of product exerts no influence on prescribing habits 
HA3 = Cost of product influences prescribing habits 
 
H04 = Medical representative has no influence on prescribing habits 
HA4 = Medical representative has an influence on prescribing habits 
 
H05 = Peers have no influence on prescribing habits 
HA5 = Peers have an influence on prescribing habits 
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Reviewed literature shows that all of the above independent variables would exert a 
positive effect on the prescribing habits of healthcare professionals. The study aimed 
to determine the key influencing variables, after the results of the empirical data were 
analysed.   
 
After a thorough review of the literature, a basic hypothesised model was developed 
before testing and is illustrated in Figure 1.1.  
 
Figure 1.1:  A hypothesised model for healthcare professional prescription 
behaviour of specialised infant formula  
 
 
Source: (Author’s own construction based on the literature review) 
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1.9 CONCLUSION 
 
Medical nutrition companies aspire to understand product requirements of healthcare 
professionals and medical representatives for direct investment to acquire market 
share without wasting resources.  MRs are the only marketing tool of IF 
manufacturing companies and therefore the face of the company for HCPs.   
 
The aim of this study was to analyse HCPs’ prescription of specialised IF by 
interviewing specific HCPs working with paediatric patients.  This is a quantitative 
study done in a positivistic paradigm.  
 
1.10 STRUCTURE OF THE RESEARCH 
 
The research is structured as follows: 
 Chapter 1:  Introduction and background to the study. 
 Chapter 2: Literature review. Personal selling as an effective selling method 
for medical representatives.  
 Chapter 3:  Methodology of the study. 
 Chapter 4:  Research results and analysis. 
 Chapter 5:  Summary of the analysis, conclusion and recommendations. 
 Reference List. 
 Appendix A:  Consistency Matrix. 
 Appendix B:  Cover Letter. 
 Appendix C:  Form E. 
 Appendix D:  Framework for Questionnaire. 
 Appendix E:  Marketing Framework. 
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Chapter 2 
LITERATURE REVIEW 
PERSONAL SELLING AS AN EFFECTIVE SELLING METHOD  
FOR MEDICAL REPRESENTATIVES 
 
2.1   INTRODUCTION 
 
Marketing has become customer-centric. Customers are recognised as the starting 
point of all marketing activities. Sales departments have begun to strategize how to 
influence customers in order to better respond to customer demand and behaviours.   
Sales departments are shifting their focus to customer care rather than attempting to 
influence customers. The result is a co-creation between marketing and customer, 
involving both interaction in product production and consumption and a reliance on 
collaboration, cooperation and communication for better end results. Collaboration, 
cooperation and communication are marketing aspects that are particularly relevant 
in personal selling in a relational selling context. This allow customers and sales 
people to work collectively towards mutually favourable ends (Shannahan, Bush, 
Moncrief and Shannahan, 2013). 
 
Due to the rising cost of sale calls, it is imperative to make the most of every 
customer-representative interaction. One call to a healthcare professional costs a 
medical nutrition company, like Nutricia, about R860. The movement towards long-
term relational exchange, the recognition that customers differ in terms of demand 
and value, also highlights the importance of personal selling. The escalating cost of 
sale calls, coupled with the increased importance of the selling function have made 
determining the characteristics of effective sales people a long-standing goal of 
managers and researchers. This has also sharpened the sales manager’s role in 
influencing the sales performance of representatives and viewing customers as sales 
team members (Shannahan, et al., 2013). A medical representative needs to make 
sure that every call is worth more than R860.   
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2.2  MARKETING OF INFANT FORMULA 
 
Marketing of infant formula is extremely regulated and has to function under strict 
constraints. Direct-to-consumer marketing strategies of infant formula have been 
associated with lowered breastfeeding rates. The WHO created the International 
Code of Marketing of Breast-milk Substitutes (ICMBS) in 1981, as part of an 
international endeavour to address the impact of marketing infant formula directly to 
consumers.  The ICMBS was formed out of concern that the aggressive marketing of 
infant formula was associated with a dramatic increase in diarrhoea, malnutrition and 
mortality in developing worlds. The code prohibited advertisement of infant formula, 
bottles, teats or gifts to healthcare professionals and mothers. Any form of marketing 
that can compete with the use of breast-milk, is covered in the above mentioned 
code (Analysis, 2015).  The implementation of the above regulation has been 
successful, but has been diluted over the years by the endless resources of the 
global pharmaceutical industry (Brady, 2012). 
 
The South African Department of Health formulated another regulation: the 
Regulation Relating to Foodstuffs for Infants and Young Children R991 on 6 
December 2012.  This regulation, R991, aims to control the marketing of IF by 
regulating the labelling, composition, packaging, sale and promotion of 
manufacturing companies (Mills, 2014.)  The R991 prohibits all promotional practices 
related to infant feeding. 
 
In this context, is it imperative for infant formula manufacturing companies to 
understand which factors influence healthcare professionals in prescribing products, 
and to design appropriate marketing strategies. The ICMBS and R991 allow only the 
marketing of products by medical representatives detailing scientific information to 
healthcare professionals.  The ICMBS and R991 trust that the healthcare 
professional will make an informed decision based on qualification and information 
shared by the medical representative. IF manufacturing aspires to understand what 
healthcare professionals are looking for in a product and in a medical representative. 
Infant formula manufacturing companies cannot obtain profits without considering 
customer satisfaction and in the case of the infant formula manufacturing company 
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sector, the primary customer is the healthcare professional prescribing infant formula 
and the sales person is the medical representative (Bassi, 2013). 
 
This study aimed to focus on the marketing of specialised infant formula, with special 
focus on CMPA.  The specialised infant formula for treating CMPA in South Africa is 
an extensive hydrolysate infant formula. The main competitor companies in the 
South African market are Nutricia, Nestlé, Novalac and Abbott.  
 
2.3 A BRIEF ANALYSIS OF THE MAJOR COMPETITORS IN THE SOUTH 
AFRICAN SPECIALISED INFANT FORMULA INDUSTRY  
 
This section focusses on four manufacturing companies. These companies are: 
Nutricia, Nestlé, Novalac and Abbott.  In South Africa, these companies manufacture 
and sell the four extensive hydrolosytes available products, which are indicated for 
CMPA.  All four products are available to the general public at pharmacies such as, 
Dischem and Clicks.  The following sub-section will discuss each company with their 
respective product range individually. 
 
2.3.1 Nutricia 
 
Nutricia is a specialised healthcare division under Danone, focused exclusively on 
scientifically-proven nutrition. The product is developed to meet the needs of patients 
and individuals for whom a normal diet is not sufficient or possible. Pepticate is 
Nutricia’s product indicated for CMPA. 
 
Table 2.1:  Nutricia summarised organisational information 
 
NUTRICIA 
Country of origin Netherlands. 
Product range Products are intended for the nutritional management of 
diseases and medical conditions.    
Products consist of specialised infant and adult feeds; enteral 
nutrition feeds for adults and infants; oral nutrition feeds for 
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adult and infants; and metabolic range of products. 
Mission statement 
 
Nutricia's mission is to lead the use of advanced medical 
nutrition in disease management and in this way to extend and 
complete Danone's mission to bring health through food to the 
greatest number of people. Nutricia has been a specialised 
division of the international food company Danone since 2007. 
Strong points 
 
Cost effective; well marketed under HCPs; product 
development is based on science. 
Weaknesses 
 
Products are imported; brand not well known by general 
public. 
Price of Pepticate R159 as on 8 November 2015. 
Source: (Compiled by author) 
 
2.3.2   Nestlé  
 
Nestlé nutrition, health and wellness portfolio aims to improve the quality of 
consumers’ lives by providing healthier and more flavoursome food with beverage 
options that encourage healthy lifestyles. Nestlé is the largest food company in the 
world, measured by revenue and ranked at number 72 on the Fortune Global 500 in 
2014.  Alfare is Nestlé’s product indicated for CMPA. 
 
Table 2.2: Nestlé summarised organisational information 
 
NESTLÉ 
Country of origin Switzerland. 
Product range Products under the Nestlé brand include: baby food, bottled 
water, breakfast cereals, confectionery, dairy products, ice 
cream, frozen food, pet foods, coffee and tea, and snacks. 
Adult and infant feeds. 
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Mission statement Nestlé is the world's leading nutrition, health and wellness 
company. Their mission of "Good Food, Good Life" aims to 
provide consumers with the most flavoursome, most nutritious 
choices in a wide range of food and beverage categories and 
eating occasions, from morning to night. 
Strong points 
 
Nestlé is a well-known house brand; product development is 
based on science. 
Weaknesses 
 
Alfare is not well marketed; product labelling did not adapt with 
the world trends; expensive. 
Price of Alfare R329 as on 8 November 2015. 
Source: (Compiled by author) 
 
2.3.3 Novalac 
 
The Novalac range is part of Pharmaco.  Ordinary infant feeding problems such as 
colic, constipation, diarrhoea and reflux in bottle fed infants are treated with Novalac 
special infant formula range. Allernova smooths is Novalac’s product indicated for 
CMPA. 
 
Table 2.3: Novalac summarised organisational information 
 
NOVALAC 
Country of origin Kenya. 
Product range Specialised infant formula designed to feed and manage 
ordinary infant feeding problems.          
Mission statement One standard for all the babies in the world. 
Strong points 
 
The formulas names are explanatory; make it easy for general 
public to understand what formula can be used for what 
condition.   
Weaknesses  Expensive; not well marketed with healthcare professionals. 
Price of Allernova 
Smooth 
R219.95 as on 8 November 2015. 
Source: (Compiled by author) 
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2.3.4 Abbott 
 
Abbott Nutrition is a division of Abbott, the global, broad-based health care company. 
Abbott provides a collection of nutritional and therapeutic products for paediatric 
patients.  Similac Alimentum is Abbott’s product indicated for CMPA. 
 
Table 2.4: Abbott summarised organisational information   
 
ABBOTT 
Country of origin America. 
Product categories The Abbott’s product range varies from nutritional products 
and laboratory diagnostics through to medical devices and 
pharmaceutical therapies, for babies, children and adults.   
Mission statement The mission of Abbott “is to improve the lives of vulnerable 
children, adults and families.  Serving children and families 
in need and people with development disabilities, Abbott 
strives for excellence and absolute integrity in the delivery 
of services,” (Abbot House). 
Strong points 
 
Products developments are based on science; company 
practice aggressive marketing techniques. 
Weaknesses:  Expensive; not a house brand. 
Price of Similac 
Alimentum 
R219.00 as on 8 November 2015. 
Source: (Compiled by author) 
 
There are four infant formula manufacturing companies in South Africa that 
manufacture IF specific indicated for CMPA.  Table 2.5 illustrates a comparison 
between the four companies.   
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Table 2.5: Comparison of Cow’s Milk Protein Allergy (CMPA) indicated formula of 
four competing companies   
 
Feature Nutricia 
(Pepticate) 
Nestlé (Alfare) Pharmaco 
(Novalac 
Allernova 
Smooth) 
Abbott 
(Similac 
Alimentum) 
Indication CMPA CMPA CMPA  CMPA 
Protein Extensively 
hydrolysed 
whey protein;  
80% whey; 
15% amino 
acid and 5% 
small chain 
peptides 
Extensively 
hydrolysed 
100% whey 
protein 
80% small 
peptides; 20% 
free amino 
acids 
39% degree of 
hydrolysis 
Extensively 
hydrolysed 
casein protein 
(supplemented 
with 60% free 
amino acids) 
Indications 
for use 
Dietary 
management 
of CMPA; 
challenge on 
formula from 
AAF 
Acute and 
chronic 
diarrhoea 
(higher MCT 
content- 
40%); Protein 
allergy 
Dietary 
management 
of CMPA. 
Severe food 
allergies; 
sensitivity to 
intact protein; 
colic due to 
protein 
sensitivity or 
fat 
malabsorption 
Availability Dischem / 
Clicks 
Dischem / 
Clicks 
Dischem / 
Clicks 
Dischem / 
Clicks 
Sale of 400g 
unit per 
month 
24 – 67 0 – 2 0 – 2 0-4 
Price per 
400g 
R159.00 R329.00 R219.95 R219.00 
Source: (Compiled by author) 
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The author asked both the managers of Dischem in Walmer Shopping Mall and in 
Cape Road for average sales figures per month as dated August 2015.   
 
2.4 RATIONALE FOR USAGE OF SPECIALISED INFANT FORMULA BASED 
ON SCIENTIFIC GUIDELINES   
 
Extensively hydrolysate infant formula is explained as follows. The protein molecules 
of extensively hydrolysed formula are broken down into free amino acids and 
peptides <1500kDa and are thus proven to be hypoallergenic, with 95% confidence. 
They do not provoke allergic reactions in 90% of infants/children with CMPA. 
Extensively hydrolysate is recommended for treatment of infants with CMPA 
(Fiocchi, et al., 2010). 
 
2.4.1    ESPGHAN guidelines 
 
ESPGHAN is a multi-professional organisation with the aim of:  
 
“… to promote the health of children with special attention to the 
gastrointestinal tract, liver and nutritional status. Through knowledge creation 
the dissemination of science based information, the promotion of best practice 
in the delivery of care and the provision of high quality education for paediatric 
gastroenterology, hepatology and nutrition professionals in Europe and 
beyond” (European Society for Paediatric Gastroenterology Hepatology and 
Nutrition, 2015: 226).   
 
The ESPGHAN guidelines state: 
 
 “The majority of infants and children with CMPA tolerate an extensively 
hydrolysed formula with whey or casein as a protein source”.  
 “The American Academy of Paediatrics (AAP) defines an extensively 
hydrolyzed formula as a formula containing only peptides that have a 
molecular weight of <3000 Da. There is currently no evidence that such a 
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threshold would guarantee the prevention of allergic reactions in infants and 
young children with CMPA”.  
 “Suitable pre-clinical testing acquire of therapeutic formulae to demonstrate in 
clinical studies a 95% confidence of not provoking an allergic reactions in 90% 
of infants or children with confirmed CMPA.  This has been shown for only 
some extensively hydrolysate formulas, up to date,” (Koletzko, et al., 2012. 
p.226).   
 
2.4.2 Australian consensus guidelines 
 
“Extensive hydrolysed formula is recommended as first choice for infants under six 
months of age for treating immediate cow’s milk protein allergy (non-anaphylactic), 
food protein-induced enterocolitis syndrome, atopic eczema, gastrointestinal 
symptoms and food protein-induced proctocolitis,” (Kemp, et al., 2008. p.110). 
 
2.4.3 American Academy of Paediatrics  
 
“Comparative studies of the various hydrolyzed formulas have also indicated that not 
all formulas have the same protective benefit in atopic disease. Extensively 
hydrolyzed formulas may be more effective than partially hydrolyzed in the 
prevention of atopic disease,” (Thygarajan and Burks, 2009. p.4). 
 
2.5 STRATEGIC PLANNING PROCESS OF MARKETING SPECIALISED 
INFANT FORMULA  
 
A strategic planning process starts with selecting an appropriate target market. This 
is one of the most important strategic decisions. The target market must be chosen 
before the organisation can adjust its marketing mix to meet the customers’ needs 
and preferences.  These two decisions are the keys to success in strategic success 
(Hult, Pride and Ferrel, 2012).  The target market in this case is healthcare 
professionals with a special interest in paediatric patients.   
 
Marketing managers need to estimate how entering the market would influence the 
company’s sales, costs and profits, before entering the market. The marketing 
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information, regarding the specialised infant formula, indicated for cow’s milk protein 
allergy, should be organised to facilitate a focus on the selected target healthcare 
professionals. Marketing should calculate whether the company has the resources to 
develop the right mix of product, price, promotion and distribution (marketing mix) to 
meet the needs of children with cow’s milk protein allergy. They should determine if 
developing an infant formula for a specialised condition is consistent with the 
company’s overall mission, vision and objectives.  The size and number of 
competitors already in this market need to be taken into account as well (Hult, et al., 
2012).  
 
The HCPs, selected as the target market, serve as the basis for creating a marketing 
mix to satisfy the needs of the market. The creation of a marketing mix is only as 
good as the IF manufacturing company’s understanding of the specific HCPs. Thus, 
this understanding typically comes from careful, in-depth research into the 
characteristics of these healthcare professionals and the external environment. 
Despite the importance of demographic information, the IF manufacturing company 
should also analyse the needs, preferences and behaviours of HCPs with respect to 
product design, pricing, distribution and promotion (Hult, et al., 2012). 
 
At the marketing mix level, an infant formula manufacturing company needs to 
specify how it will achieve a competitive advantage. To gain this advantage, the 
infant formula manufacturing company must be more innovative than its competitors. 
In addition its products must be of a superior quality, its prices must be constant with 
the level of quality and its distribution methods must be proficient and cost-effective. 
Furthermore, promotions must be more effective than those of the competitors. 
These competitive advantages should also be sustainable. A sustainable competitive 
advantage is one that the competition cannot duplicate in the foreseeable future 
(Hult, et al., 2012).  
 
2.5.1  Marketing specialised infant formula to healthcare professionals  
 
The infant formula industry operates under strict regulations, as previously 
explained.  The regulations force companies to market products through healthcare 
professionals by making use of medical representatives. Therefore the consumer is 
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the healthcare professional rather than the parent. Medical representatives promote 
their products by providing valuable information to healthcare professionals in 
exchange for product prescriptions. Four conditions must exist, according to Hult, et 
al. (2012) for an exchange to take place: 
 
1. Each party of two or more individuals, groups, or organisations must 
participate and hold something of value that the other party desires. 
2. The exchange should grant an advantage to both parties in the transaction.   
3. Both parties should have assurance in the ‘something of value’, held by the 
other party. 
4. The parties to the exchange should meet expectations in order to build trust.   
 
Infant formula manufacturing companies make use of personal selling techniques to 
market their products to HCPs. ‘Personal selling’ is a person that is paid to 
communicate effectively to customers in order to convince them to purchase 
products (Hult, et al., 2012).  The specific activities involved in the selling process 
vary among representatives, selling situations and culture. This process consists of 
seven steps: 
 
1. Prospecting - developing a database of potential healthcare professionals.  
2. Pre-approach - the MR finds and analyses information about each HCP’s 
prescribing behaviour, which includes product needs, current use of brands, 
perception of brands, concepts and personal characteristics. 
3. Approach - the way in which a MR approaches a potential HCP.  
4. Making the presentation - during the presentation the MR must attain and hold 
the HCP’s attention, stimulate interest as well as an aspiration for the product. 
5. Overcoming objections - a successful MR seeks or identifies a HCP’s 
objections in order to address them.  
6. Closing the sale - the stage in the personal selling process when the MR asks 
the HCP to prescribe the product. 
7. Follow up - after a successful closing, the representative determines whether 
the desired results were achieved by product usage (Hult, et al., 2012). 
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2.6 PERSONAL SELLING APPROACH OF A MEDICAL REPRESENTATIVE  
 
Personal selling goals vary from one company to another.  They usually involve 
finding healthcare professionals, determining their needs, persuading healthcare 
professionals to prescribe the product, following up after prescribing and keeping 
healthcare professionals satisfied (Hult, et al., 2012).  
 
Marketing scholars and practitioners embrace two important environmental shifts in 
marketing, according to Richard and Jones (2009). These environment shifts are: 
 
1. A shift from short-term transactional exchanges to long-term relational 
exchanges. 
2. Marketers do not assume that customer demand is homogenous anymore, 
and accept the realism that customer demand is diverse with respect to the 
worth they provide for the selling firm (Richard and Jones, 2009). 
 
Two forms of personal selling approaches, which are transactional and relational 
selling techniques, will be explained in the following sections.  
 
2.6.1   Transactional selling 
 
A transactional selling approach emphasises the current exchange, getting the order, 
as the near-term outcome of the selling activity. Transactional selling strategies 
focus on persuading the customer to buy, and often include the use of sales 
activities designed to stimulate demand and alternate between generating customer 
interest, overcoming objections and closing the sale. Representatives who practice 
transactional selling focus on creating new business rather than allocating 
considerable efforts and resources to guarantee customer satisfaction and retention 
and thus do not emphasise the long-term benefits of maintaining durable customer 
relationships (Autry, Williams and Moncrief, 2013). 
 
Transactional selling emphasises the current exchange. The focus is on convincing 
the healthcare professional to prescribe through the use of sales presentations to 
build the prospect’s interest, overcome objections and successfully close the sale at 
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a price that satisfies revenue and profit needs. Communication focuses on explaining 
how product/service matches with the healthcare professional’s needs and 
persuading the healthcare professional that proposed products are better than the 
competitors (Autry, et al., 2013). 
 
2.6.2 Relational selling 
 
Relational selling involves building mutually beneficial long-term associations with a 
healthcare professional through regular communication over prolonged periods of 
time. This is also known as consultative selling  (Autry, et al., 2013). Relational 
selling consists of finding solutions to HCPs’ requests by listening to them, 
formulating a detailed understanding of their practice, understanding and caring 
about their needs and challenges and providing follow up support (Hult, et al., 2012). 
 
Transactional selling focuses on immediate exchange outcomes, compared to the 
relational selling approach which focuses on initiating and building jointly beneficial 
relationships for future interactions between parties. The MR replaces persuasive 
tactics with cooperative intentions and actions, frequent contacts, highly collaborative 
communication and mutual disclosure in order to generate and cherish the shared 
trust that allows HCPs and MRs to fully share information and work together as a 
strategic problem solving team (Slater and Olson, 2000). Relational selling involves 
creative problem solving and generating innovative solutions that the healthcare 
professional may not have otherwise identified and that yield value for both parties 
exceeding that of the core product knowledge being exchanged. In relational selling, 
the representative serves as relationship manager and value creator through the 
identification of new alternatives aligned with the needs of the healthcare 
professional and capabilities of the representative  (Autry, et al., 2013).   
 
Relational selling strategies often lead to higher costs, investments and risks 
compared to transactional strategies (Giacobbe, Donald, Crosby and Bridges, 2006; 
Guenzi, Pardo and Georges, 2007) and not all customers desire relational 
exchanges. Associated costs can exceed the perceived benefits and miss-applied 
relational selling strategies can be counterproductive, resulting in negative customer 
reactions. Autry, et al. (2013) argue that representatives have the opportunity to 
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match their behaviour to the specific healthcare professional situation they 
encounter, by the use of knowledge about the healthcare professional and 
prescribing nature to adapt the detailing approach.  This is known as the adaptive 
sales approach. The adaptive sales approach has become the standard for 
implementing transactional selling and relational selling approaches. 
 
2.6.3 Essential components in relational selling techniques   
 
Consumers are more likely to engage with sales people who are physically attractive 
and appear to be motivated by the pleasant experience of interacting with attractive 
sales people (Xie and Kahle, 2014). 
 
Knowledge about effective selling strategies in specific situations is a critical 
ingredient for effective sales. The contingency model for sales person effectiveness 
details two levels of situational contingencies that affect performance. These two 
levels are: 
 
1. The characteristics of the sales person, for example the capabilities, 
qualification, resources, selling strategy, personality and support from the 
organisation. 
2. The characteristics of the buyer, for example type of healthcare professional, 
type of medical practise, type of clientele, complexity of situation and 
prescribing behaviour (Autry, et al., 2013). 
 
Giacobbe, et al. (2006) characterise selling situations that are favourable in these 
traits as the ‘adaptive condition’, a selling situation in which one expects adaptive 
selling behaviour to be effective, and vice versa. Giacobbe, et al. (2006) emphasise 
that the selling conditions play an essential role in the adaptive selling behaviour and 
sales performance, and the adaptive sales condition shows a stronger positive sales 
performance (Giacobbe, et al., 2006). 
 
Arnett and Badrinarayanan (2005) affirm that trust is an essential component in all 
relational exchanges and exists when one party has full assurance in the reliability 
and integrity of the exchange partner. An exchange transaction done in the context 
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of a trusting relationship will exceed the expectations of both parties. Trust between 
a healthcare professional and a representative is important because trust enhances 
prescription intention and satisfaction. Erevelles and Fukawa (2013) state that a 
customer’s perception of a sales person’s expertise is positively related to the 
customer’s trust of the sales person. Interpersonal liking mediates the development 
of trust between a customer and a sales person. Research indicates that the 
mediating effect of liking overshadows cognitive antecedents. The antecedent 
emotions can include: the sales person’s appearance (Kim, Hae and Kim, 2009); 
perceived attributes of a sales person (e.g. trustworthiness, expertise, friendliness, 
accessibility, empathy and professional appearance of a sales person) (Lee and 
Dubinsky 2003; Lee, Comer, Dubinsky and Schafer, 2011) and sales person 
stereotype of trust in the relationship as it matures.  A mature relationship between a 
healthcare professional and medical representative will positively overshadow 
antecedent emotions (Erevelles and Fukawa, 2013). 
 
Healthcare professionals respond positively to informative knowledge through 
information sharing by representatives.  Information sharing is seen as the sharing of 
information between the buying and selling organisation that may be important for 
future transactions between parties (Richards and Jones, 2009). Informative 
information sharing is a significant factor in relationship development success.  
Knowledgeable representatives develop successful relationships which lead to 
improved financial performance of companies (Richards and Jones, 2009).  Mallalieu 
and Kent (2008) indicated in a study that consumer mind-sets can affect consumer 
perceptions of helpfulness of sales people: an assessment mind-set elicits higher 
needs for information from sales people, but an action mind-set induces a motivation 
to complete the purchase as a task. When sales people reveal their product 
knowledge and expertise, consumers in an assessment mind-set perceive sales 
people as more facilitating than those in an action mind-set (Xie and Kahle, 2014). 
 
Relationship commitment is also an important ingredient of relational exchanges. It is 
defined as a continuing aspiration to uphold a treasured relationship. Research 
suggests that relationship commitment is at the centre of all successful working 
relationships and that it is an essential ingredient in successful long-term 
relationships, including HCP - MR relationships. Relationship commitment provides a 
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solid base from which additional characteristics important to the development of 
relationships can be built upon (Arnett and Badrinarayanan, 2005). A study of buyer-
seller relationships, conducted by Autry, et al. (2013), notes that while sellers are 
generally shifting away from transactional selling approaches and toward long-term 
relational exchanges, 95 percent (95%) of participating sales people report having 
experienced selling task conflicts in their relationships (Autry, et al., 2013). 
 
Erevelles and Fukawa (2013) conclude that an unhappy customer feels even worse 
when interacting with a happy sales person, due to the discrepancy between each 
other’s moods, resulting in a lower evaluation of the products promoted by that 
happy sales person. Kidwell, McFarland and Avila (2007) find that a sales person’s 
ability to perceive customers’ emotions facilitates their use of adaptive selling and 
customer oriented selling in improving sales performance (Kidwell, et al., 2007). 
Similar to this, Byron, Terranova and Nowicki (2007) find that the better the sales 
person’s ability is to assess nonverbal cues, the more successful the sales person is 
likely to be in sales performance (Byron, et al., 2007).  The study of Kidwell, 
Hardesty, Murtha and Sheng (2011) suggests that sales people with higher 
emotional intelligence not only generate higher revenue but also retain customers 
better than those with lower emotional intelligence (Kidwell, et al., 2011). Emotional 
intelligence is the capability to assess and understand your own emotions as well as 
those of others and to use this understanding in formulating one’s thoughts and 
behaviours (Rozell, Pettijohn and Parker, 2006). Erevelles and Fukawa (2013) 
suggest that sales people with higher emotional intelligence show better coping 
behaviour in emotionally challenging situations than those with lower emotional 
intelligence (Erevelles and Fukawa, 2013).  Bagozzi, Belschak and Verbeke (2010) 
further argue that sales people with higher emotional intelligence take their own 
interests and also other people’s interests, into consideration. Such sales people 
tend to earn the trust of others more easily and build better social relationships with 
colleagues, customers and others (Bagozzi, et al., 2010). 
 
2.6.4   Customer-oriented approach in relational selling 
 
The marketing literature has increasingly advocated a customer-oriented approach 
and more recent perspectives of the personal selling process are to focus on 
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information coming from the prospective customer. The realities of relational selling 
in an information demanding environment emphasise the fundamental role the 
customer plays as a provider of information in the sales process (Shannahan, et al., 
2013). The evolved selling process reveals a customer orientation with the focus on 
relational selling. Consequently, the selling process has mostly evolved to securing, 
building and maintaining long-term relationships with profitable customers.  
 
Other factors besides individual skills of the sales person are needed to drive the 
personal selling process and performance sales (Shannahan, et al., 2013). It 
requires access to the right information, which is disseminated to the right people 
and coordination between the healthcare professional and sales person in order to 
deliver optimal value. Since this research study is in a relational selling context, 
healthcare professionals have the opportunity to participate in and impact the 
detailing process as they work with medical representatives to identify problems. 
They can also determine needs, propose and implement effective solutions and they 
too should be regarded as a major force in the immediate work environment of the 
medical representative. Thus, healthcare professionals are important contributors to 
the success of the infant formula manufacturing company. 
 
2.7 PERSONAL SELLING AND ORGANISATIONAL LEARNING  
 
Organisational learning consists of three phases: medical representative / healthcare 
professional perception of cues, interpretation and action / response.  These phases 
are illustrated in Figure 2.1 below.  While information perception, interpretation and 
response can occur during single healthcare professional-medical representative 
encounters, it also occurs outside. Both professions often consult with other peers on 
practical solutions to approach a specific situation. Medical representative are 
responsible for scanning, interpreting and acting on information from the 
environment.   
 
The second organisational learning stage, interpretation, is the process whereby 
information gains value and results in certain behaviour. Interpretation is made 
possible through individuals’ ability to recognise and reconcile irregularity and make 
do with bits of information. Healthcare professional communication cues are 
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important parts of information that are open to interpretation by a medical 
representative. Only after medical representatives interpret and make sense of what 
they perceive, can they formulate a response and contribute to the organisation they 
create with the healthcare professional (Shannahan, et al., 2013).   
 
The final stage of the organisational learning process occurs when the medical 
representative takes an action or response. Selling steps, activities or techniques 
can be viewed as medical representative actions or responses that are taken 
because their perceptions and interpretations dictate they are appropriate. Figure 2.1 
illustrates one healthcare professional (HCP) action that can be perceived by a 
medical representative (MR).  Possible healthcare professional responses include 
agreeing to further meetings, providing more information or engaging other 
healthcare professionals. Such an action is likely to be interpreted favourably by a 
medical representative since prospecting is an expensive procedure that typically 
takes multiple calls to uncover someone who may or may not become a bona fide 
prospect (Shannahan, et al., 2013). 
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Figure 2.1: Medical representative (MR) - healthcare professional (HCP) 
organisation as a contributor to organisational learning from each perspective 
 
 
Source: (Adapted by author from Shannahan, et al., 2013) 
 
2.8 THE PERSONAL SELLING PROCESS AS AN INTERPRETATION SYSTEM 
 
HCP-MR relationships in a relational selling context rely on an understanding 
between the healthcare professional and the medical representative so that they can 
come to a mutually beneficial solution together. These relationships are 
characterised by patterns of interaction in which an individual’s words and actions 
affect how the other  responds as information is acquired, interpreted and responded 
to (Shannahan, et al., 2013). 
 
37 
 
The personal selling process can be thought of as an interpretation system 
comprising of individuals with the goal of reducing uncertainty with respect to each 
facet of the evolved selling aspects. It is notable that each of the evolved steps relies 
on the acquisition and interpretation of information that is often provided to medical 
representatives by healthcare professionals. However, healthcare professionals may 
offer information, the information must be perceived, correctly interpreted and 
appropriately responded to by the medical representative to facilitate the prescribing 
process (Shannahan, et al., 2013). 
 
The aspect of nurturing the relationship (relational selling) is particularly reliant on 
information acquired from and participation of the healthcare professional as this is 
where needs, problems and concerns are fleshed out. As for marketing the product, 
the role of the healthcare professional is just as pronounced. The healthcare 
professional needs to be an active participant in product development, posing key 
questions and providing vital information in working with the medical representative. 
The healthcare professional contributes by adding value and satisfying needs 
through identifying mutual goals between the detailer and the prescriber. 
Maintenance of professional healthcare relationships is characterised by continued 
healthcare professional contact in an effort to build business.   
 
As seen in Figure 2.2, every aspect of the personal selling process within the 
evolved selling paradigm allows for the healthcare professional (HCP) to actively 
participate in and affect the selling process through the provision of information and 
other communication cues (Moncrief and Marshall, 2005). Thus, at every step the 
MR is presented with the opportunity to use the information acquired from the 
interaction in an attempt to remove uncertainty. In addition, accounts and routines 
with respect to the opportunity with a particular healthcare professional are 
developed.  Alternatively, at every step, the healthcare professional uses information 
acquired during interactions with the medical representative to try to remove 
uncertainty regarding the medical representative’s ability to meet the buying firm’s 
needs. Figure 2.2 also reinforces that uncertainty and equivocality can arise at any 
time and that ecological change can be associated with every aspect of the personal 
selling process (Shannahan, et al., 2013). 
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Figure 2.2: Representation of the uncertainty, equivocality and opportunity for 
ecological change surrounding the HCP-MR organisation that occurs during every 
interaction and affects every aspect of the evolved selling process   
 
 
Source: (Adapted by author, based on Moncrief and Marshall, 2005; Shannahan, et 
al., 2013). 
 
The personal selling process can be treated as an interpretation system. The 
adoption of an organisational communication perspective of personal selling allows 
for the development of a conceptual framework in which to explore the influence of 
healthcare professionals’ communication cues on the personal selling process and 
medical representative performance (Shannahan, et al., 2013). 
 
2.9 NEGATIVE AFFECT IN PERSONAL SELLING 
 
Negative affective situations common in sales contexts include: embarrassment, 
sales call anxiety, stress and emotional exhaustion. Verbeke and Bagozzi (2000) 
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suggest that both in canvassing and closing, two common types of selling situations 
exist, namely negative affectivity and anxiety-provoking contextual cues. These cues 
affect four dimensions of an anxious sales call: negative self-evaluations, negative 
evaluations from customers, awareness of physiological symptoms and protective 
actions (Verbeke and Bagozzi, 2000). They also suggest that these four dimensions 
of anxiety negatively affect both communication performance and sales quantity 
performance (Erevelles and Fukawa, 2013). 
 
Healthcare professionals in a detailing scenario can also experience negative 
emotions. Customers may experience guilt after interacting with a sales person and 
therefore decide not to prescribe the product. Once a customer interacts with a sales 
person and feels a social connectedness, the lack of a purchase induces a feeling of 
guilt within the customer, which in turn fosters a need to engage in a behaviour that 
would benefit the sales person (e.g. future intentions of purchasing something from 
the sales person) (Erevelles and Fukawa, 2013). 
 
Extant research done by Xie and Kahle (2014) has examined consumer perceptions 
of sales agents, product evaluations and purchase intentions as a result of personal 
selling attempts. In general, sales people attempt to persuade consumers towards 
the adoption of beliefs, positions or courses of action by means of argument, 
enticement or reasoning. Some of the persuasion tactics are socially acceptable, but 
others are viewed as devious, deceptive or unethical.  Researchers suggest that 
consumers are not merely passive receivers of persuasion tactics, but are practical 
participants who have their own objectives and are capable of selecting their own 
reactions to the sales situation (Xie and Kahle, 2014). 
 
2.10  SALES ETHICS 
 
Wenxia and Main (2012) suggest that defensive motivations affect consumer 
behaviour in response to personal selling.  For instance, when a consumer realizes 
that a sales person has ulterior selling motives, they tend to perceive the sales 
person’s behaviours (e.g. a positive remark on consumer product choice) as 
insincere and manipulative. As a result, they react less favourably towards the sales 
person (Xie and Kahle, 2014). 
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Research done by Erevelles and Fukawa (2013) disclose that sales people are 
sometimes perceived as being less than ethical in their interactions with their 
customers.  A study of sales executives suggest that at least 50 percent (50%) 
suspect that their sales people may have lied to their clients and 75 percent (75%) 
believe that their sales people may have stopped focusing on their clients’ needs 
(Erevelles and Fukawa, 2013). 
 
Erevelles and Fukawa (2013) also investigate how customers form ethical 
perceptions and subsequent effects of these perceptions on customer emotions and 
purchase intentions while interacting with a sales person. They find that moral equity 
(a customer’s perception that they have been treated fairly by a sales person) fosters 
positive emotions and inhibits negative emotions. They also find that while positive 
emotions enhance future purchase intentions, negative emotions hinder future 
purchase intentions (Erevelles and Fukawa, 2013). 
 
2.11  MANAGERIAL RELEVANCE OF PERSONAL SELLING   
 
Since some healthcare professionals are more willing than others to invest time and 
effort in an exchange relationship, it is important to identify healthcare professionals’ 
communication cues and to develop and compile accounts that have positive effects 
on the personal selling process and on sales performance. What is more, the goals 
and objectives of infant formula manufacturing companies with respect to particular 
healthcare professional relationships are sometimes broader than mere sales 
volume. Encouraging medical representatives to identify and benefit from healthcare 
professional cues may result in the facilitation of the selling process and contribute to 
the achievement of other organisational goals and objectives, such as lowering 
costs, enhancing profitability or gaining broader market access (Jones, Dixon, 
Chonko and Cannon, 2005). Managers who understand this concept can adapt their 
training programs to focus on medical representative attention, interpretation and 
response to all healthcare professional communication cues (Shannahan, et al., 
2013). 
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Managers of customer-oriented firms should view healthcare professionals as an 
extended part of the company itself.  From a managerial perspective, understanding 
which pre-sale healthcare professional cues facilitate selling efforts and help drive 
medical representative performance is important not only for developing sales 
training but also for prioritising customers. As medical representatives intently 
perceive, accordingly interpret and appropriately respond to healthcare 
professionals’ cues, the results should be a better understanding of customer sales 
cycles, more accurate sales forecasts and easier identification of key opinion 
leaders. Those medical representatives with the ability to perceive, interpret and 
respond to customer cues and to use accounts gathered over time are among a 
firms’ most effective and productive employees (Shannahan, et al., 2013). 
 
Previous research points out that closer relationships do not always translate to 
enhanced performance and that transactional customers can offer the same levels of 
profitability as relational customers. Firms should focus on extending micro-
segmentation to better understand how their buyers prefer to buy and co-align sales 
approaches with purchasing preferences.  This will convert into more strategic selling 
resources and managers can better allocate sales resources to meet buyer needs 
and expectations (Autry, et al., 2013). 
 
The efficacy of a medical representative to employ both transactional and relational 
selling approaches effectively for the purpose of generating sales performance, in 
the right selling situation, can be regarded as relevant to management (Autry, et al., 
2013). 
 
2.12  DISCUSSION 
 
Although current medical representatives are constantly under pressure to deliver 
revenue for their organisations, there is a general lack of consensus as to precisely 
what behavioural approaches are most effective in generating positive returns. 
Reflecting the tenets of adaptive selling and the increasing emphasis on relational 
selling, managers guide their sales people to strategically diverge their approaches 
to the buying situation (Autry, et al., 2013). In today’s competitive marketplace, 
creativity is critical if an organisation expects to achieve a competitive advantage, 
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even in the short term. Creativity is also extremely important in sales contexts, as the 
creativity of a medical representative may facilitate their sales performance (Wang 
and Netemeyer, 2004).  
 
2.13  CONCLUSION 
 
Personal selling, especially in a relational selling context, provides an example of a 
loosely coupled system in that healthcare professionals and medical representatives, 
while responsive to one another as they work together, retain separateness and 
identity since each belongs to a formally structured organisation (Shannahan, et al., 
2013). The personal selling process provides an opportunity for healthcare 
professionals and medical representatives to be active participants in the 
development of a working relationship and sharing of informative knowledge. This 
process can be used to enhance and sustain an infant formula manufacturing 
company’s competitive advantage.   
  
The personal selling process contributes to organisational learning because after 
each interaction, both parties return to their respective formally structured 
organisations to make sense of their interaction and observation, and to formulate 
the next steps or opinion of discussed products. As healthcare professionals and 
medical representatives organize, each tries to make sense of their immediate 
situation by observing, interpreting and responding to the communication cues of the 
other.  
 
Leigh and Marshall (2001) view the healthcare professional as an actively involved 
relationship and communication partner, in the relational selling contexts.  MRs’ aim 
to work with healthcare professionals to reduce ambiguity and generate trust and 
confidence, by forming effective working relationships. A further objective they have 
is to adapt selling strategy to fit the healthcare professional’s personality, clientele, 
environment and work ethics. The end result of a medical representative’s efforts is 
to practice personal selling techniques to generate a return of investment for infant 
formula manufacturing companies, after every personal selling session, with a 
healthcare professional. Although medical representatives execute a multitude of 
tasks through the course of the personal selling process, the success of this process 
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is ultimately a function of a successful relationship between a healthcare 
professional and a medical representative (Leigh and Marshall, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
Chapter 3 
METHODOLOGY OF THE STUDY 
 
3.1  INTRODUCTION 
 
The preceding chapters, including the literature review and a hypothetical model 
introduced the reader to the concepts of specialised infant formula indicated for 
cow’s milk protein allergy, the various companies in the South African market and 
the personal selling role of the medical representative.     
 
This chapter provides an overview of the research methods used and attempts to 
collect, analyse and interpret empirical data with the aim of establishing the reliability 
of the afore mentioned framework.   
 
3.2  RESEARCH PARADIGM 
 
Deciding on the appropriate method for collecting and analysing research data and 
applying it meticulously, is emphasised by Collis and Hussey (2014). They state that 
research means different things to different people and that there is no consensus in 
the literature of how it should be defined. The selection of meaning can be 
summarised as follows: 
 
 a process of inquiry and investigation; 
 systematic and methodical; and 
 increases knowledge. 
 
Every effort was made by the researcher to adhere to the above mentioned 
principles of research. Collis and Hussey (2014) state that a research paradigm is a 
philosophical framework guiding the way scientific research should be conducted, 
based on people’s philosophies and their assumptions about the world and the 
nature of knowledge  (Collis and Hussey, 2014: 10). 
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The research paradigm is usually refined into two major philosophical doctrines of 
social and research inquiry.  These are the positivistic approach and the 
interpretivism approach. The positivistic philosophy is associated with a quantitative 
approach to investigation while the interpretivism approach is associated with a 
qualitative approach to research (Collis and Hussey, 2014).  The differentiation 
between the two approaches can be seen in Table 3.1 to facilitate understanding 
and simple comparison. 
 
Table 3.1: Positivist vs. Interpretivism 
 
 Positivistic Interpretivism 
Terms Quantitative; objectivist;  
scientific; experimentalist; 
traditionalist; empiricist. 
Qualitative; subjectivist; 
humanistic; interpretivist; new 
mind-set. 
Assumptions 
Ontological  
(What is the nature 
of reality?) 
Reality singular and 
objective; apart from the 
observer. 
Realities are multiple and 
subjective; observer integral. 
Epistemological 
(What constitutes 
valid knowledge?) 
Researcher independent 
from that being research; 
knowledge comes from 
objective evidence about 
observable and measurable 
phenomena. 
Researcher interacts with 
that being research; 
knowledge comes from 
subjective evidence from 
participants. 
Methodological 
(What is the 
process of 
research?) 
Quantitative: deductive;  
cause and effect; static 
design - categories isolated 
before study; context free;  
generalisations leading to 
predictions; explanation and 
understanding; and accurate 
and reliable through validity 
and reliability. 
Qualitative: inductive;  
mutual simultaneous shaping 
of factors; emerging design - 
categories identified during 
research process; context 
bound; patterns, theories 
developed for understanding; 
and accurate and reliable 
through verification. 
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Axiological 
(What is the role of 
values?) 
Value-free and unbiased. Value-laden and biased. 
Rhetorical 
assumption 
(What is the 
language of the 
research?) 
Formal; based on set 
definitions; impersonal voice; 
use of quantitative words. 
Informal; evolving decisions; 
personal voice; use of 
qualitative words. 
Philosophical 
inquiry 
The physical and social 
reality is independent of 
those who observe; 
observation equates to 
scientific knowledge. 
Social reality is constructed 
by those who participate in it 
and will be different for each 
individual; individuals build 
their own understanding of 
the world through experience 
and maturation. 
Research design Determinations and trends of 
defined population; usually 
large samples with relatively 
small exploration to 
understand the population. 
Multiple social realities 
studied; individuals must 
reveal their social realities 
(including the researcher); 
usually small samples with 
in-depth exploration. 
Data collection 
and design 
Mathematics and hard 
statistics used to analyse; 
variables expressed as 
numerical scales. 
Study of individual cases, 
descriptions observed; 
analytic induction. 
Research 
methods 
Surveys: descriptive and 
analytical; experimental 
studies; cross-sectional 
studies; longitudinal studies. 
Hermeneutics; ethnography; 
participative inquiry; action 
research; case studies; 
grounded theory; feminist, 
gender and ethnicity studies; 
interviews. 
Major criticisms It is impossible to treat 
people as being separate 
Qualitative data are too 
subjective and susceptible to 
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from their social context and 
they cannot be understood 
without examining the 
perception they have of their 
own activities; 
A highly structured research 
design imposes certain 
constraints on the result and 
may ignore more relevant 
and interesting findings; 
Researchers are not 
objective, but part of what 
they observe.  They bring 
their own interests and value 
to the research; capturing 
complex phenomena in a 
single measure is, at best, 
misleading.   
bias in data collection and 
interpretation; Such research 
provides an unstable 
foundation for expensive and 
critical business decisions; 
results cannot be generalised 
from a qualitative study to a 
larger population. 
Source: (Adapted by author based on Wegner, 2012; Leeching, 2013; Arnolds, 2014; 
Collis and Hussey, 2014) 
 
Although at first the quantitative and qualitative dichotomy may seem apparent when 
the differences are listed in a table, the reality is usually far more uncertain.  The 
paradigm that has been adopted to facilitate the research has endeavoured to utilise 
the scientific rigour of the positivistic or quantitative approach to establish the linkage 
between the dependent variable (prescription) and a selected set of proposed 
independent variables (manufacturing company; product composition; cost of 
product; medical representative; and peers). Throughout the process, all stages of 
progress were discussed with and referred to a panel of selected advisors in an 
effort to enhance the validity and reliability of the data collected. The panel consisted 
of: 
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 Mrs Y van der Westhuizen. Occupational Therapist and senior therapist at 
Kouga sub-district, Eastern Cape, Department of Health. 
 Mrs M Roberts. Dietician, Sales representative of Aspen Pharmaceutical 
 Mrs Kimberly Heikeman. Physiotherapist, Kouga sub-district, Humansdorp 
Department of Health. 
 
The quantitative method for the study is highlighted in Figure 3.1 below. 
 
Figure 3.1:  Quantitative method adopted for the study  
 
Source: (Author’s own construction) 
 
3.3  RESEARCH DESIGN 
 
Research design is a sequence of steps that connects the empirical data to the 
research questions raised by the study. Research designs are logical blueprints.  
Every research study has a design, whether implicit or explicit. Researchers seek to 
use powerful designs to strengthen the validity of their studies to ensure that the data 
is collected properly to address the research topic being studied. In this way the 
conclusions drawn by the study can be linked back to the very seed questions that 
brought it about.  Patterns or theories are developed for quantitative research to 
understand phenomenon through an inductive process (Collis and Hussey, 2014). 
 
It was clear after the secondary literature review was completed, that the preferred 
method for collection of empirical information in the field of healthcare prescription 
was via interviews with HCPs. Interviews are a popular method for collecting 
research data.  The researcher needs to clarify what information is needed and this 
may be guided by a conceptual framework developed from the literature. The 
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researcher also needs to determine beforehand how information will be captured. 
Interviews can be conducted with individuals or groups, using a variety of methods 
that include, face to face, telephonic and online. Each method has different strengths 
and weaknesses.  Appropriate methods for a particular study may depend on the 
size, location and accessibility of the sample as cost is often an important factor 
(Collis and Hussey, 2014). 
 
The researcher decided to interview healthcare professionals individually if they were 
in practice on their own or in groups (of two or three) if they were two or more in a 
practice. The reasoning behind this strategy is that healthcare professionals, who 
work together as a team, tend to give information more freely amongst one another. 
The researcher paid special attention to obtain answers from every individual in the 
group.   
 
3.4  POPULATION AND SAMPLE 
 
3.4.1  Population 
 
The target population investigated was healthcare professionals who work with 
infants with specialised conditions. The healthcare professionals included in this 
sample consisted of paediatricians, dieticians and nurses within Port Elizabeth.  This 
population was chosen because parents take their children to these specific HCPs 
for evaluation and advice regarding the purchase of the correct specialised infant 
formula.   
 
3.4.2  Sample and sampling method 
 
A sample must be representative of its target population to produce valid and reliable 
characteristics of the whole population (Wegner, 2012). Under a positivistic 
paradigm, the research data is analysed statistically with a view to generalising from 
the sample to the population (Collis and Hussy, 2014). Researchers rarely survey 
the entire population as it is often not possible to record every data value of the 
population, mainly because of cost, time and effort of doing so is usually very high. 
Sampling allows researchers to reduce costs, expedite data collection and permit 
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easier processing of the collected information (Wegner, 2012).  A sample will ideally 
be accurate (there is an absence of bias) and precise (the sample represents the 
population well) but achieving this requires effort and planning (Arnolds, 2014).  
 
Figure 3.2:  Target population, sample units, sample elements and actual sample 
size of the study 
 
 
(Source:  Compiled by author) 
 
Sampling can be done by using either probability or non-probability methods.  
Probability methods rely on chance selection of participants, while non-probability 
methods rely on subjective selection (Wegner, 2012).  Table 3.2 illustrates the 
differences between these two sampling methods. 
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Table 3.2: Probability and non-probability sampling 
 
PROBABILITY NON-PROBABILITY 
Simple Sample chosen 
randomly, equal 
possibility of being 
selected. 
Convenience Subjects chosen by 
availability. 
Systematic Population is ordered, 
sample taken at intervals, 
unequal chance of 
selection. 
Purposive Selection of subjects 
with specific traits. 
Stratified Population grouped by 
characteristics, random 
sample taken from each 
group, avoids unequal 
representation. 
Snowballing Subjects nominate 
others who fit inclusion 
criteria. 
Quota Stratified with specific 
numbers per group, 
groups may be unequally 
represented. 
Volunteer Canvassing or 
advertising for subjects, 
inviting people to fill out 
questionnaire. 
Cluster Population divided into 
sub-populations, 
randomly selected 
clusters, includes all in 
selected clusters. 
  
Source: Wegner (2012) 
 
The selected sample was derived from the contact database of a MR in the selected 
area.  Therefore this is regarded as a non-probability convenience sample as the set 
of contact details was readily available to the researcher. However convenience 
sampling is not a preferred sampling method. This is likely to produce an unknown 
degree of incompleteness or bias, as the most readily available sources of data are 
not likely to be the most informative sources (Yin, 2011). The deciding factors for 
settling on this specific sampling method were because the sample was easily 
available and there were no associated costs.  It is not relevant to gather probability 
samples from the larger population, as the selected sample deals with the specific 
topic under discussion.  Only a small number of healthcare professionals in Port 
Elizabeth are involved in scripting specialised infant formula. All of the healthcare 
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professionals in the Eastern Cape were not included in this study because of 
practicality, feasibility and time constraints.     
 
The sample of healthcare professionals scripting specialised infant formula in Port 
Elizabeth included 63 individuals. The researcher conducted interviews with 
respondents which varied in length from 4:36 to 37:44 minutes. The interview 
framework consisted of five independent variables, therefore it was hoped that there 
would be a minimum of 25 respondents to give the results more credence (minimum 
of five responses per measurable variable) (Arnolds, 2014). This study is classified 
as a narrower level, 25 to 50 respondents.  At the narrower level, the general 
preference for larger over smaller numbers still persists (Yin, 2011).  The researcher 
focused on respondents who deal with the specific topic under discussion, therefore 
accepting a narrower study and focused on the complexity and depth of data 
collection.  The potential number of respondents for each profession is illustrated 
below in Table 3.3. 
 
Table 3.3: Potential respondents from healthcare professionals scripting specialised 
infant formula in Port Elizabeth 
 
Respondent type Potential number 
Paediatrician 12 
Dietician 31 
Nurse 20 
TOTAL 63 
Source:  (Author’s own construction based on Medical Representative Database) 
 
3.5  THE RESEARCH INSTRUMENT 
 
The research instrument measures exist to numerically represent degrees of 
attributes. Quantitative research is based on measurement and is conducted in a 
systematic, controlled manner. These measures enable researchers to perform 
statistical tests, analyze differences between groups, and determine the preferred 
behaviour. If something is not measurable, it cannot be tested (Hagan, 2014).   
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A structured research instrument was used in this study.  Respondents were 
interviewed in a conversational mode, through the question-and-answer format.  
Open ended questions were used to add depth to issues under discussion.  The 
structured instrument used need to have predictable features:   
 
 It should consist of sufficient questions, central to the topic being studied that 
guide the interviewer. 
 The researcher should keep the protocol as a mental framework while 
collecting a variety of data without the need to page through documents.   
 The framework, should point to opportunities to search for contrary as well as 
supporting evidence. 
 The questions on the protocol will help the researcher to attempt for 
converging and triangulating evidence. 
 The researcher should use the framework as guidance and should also think 
outside of the framework for the likelihood of discovering new insights during 
data collection (Yin, 2011). 
 
The research instrument for this study consisted of closed ended statements, 
requiring the respondent to register their degree of important or not important with 
the sentiments expressed, as well as open ended questions requiring the respondent 
to express personal opinion. The researcher also asked the question why often, to 
uncover the true meaning of statements. The researcher investigated further, by 
asking more specific questions, after the majority of respondents gave the same 
answers. The design of the framework, according to Wegner (2012) is of utmost 
importance in ensuring that the collected data is appropriate, accurate and credible 
(Wegner, 2012). Statements were short and simple with no jargon or uncertainty and 
context for the research was given in a cover letter, Appendix B. The guidance from 
Collis and Hussey (2014) was followed and every effort was made to use an 
effective design. A concerted effort was made to uphold high ethical standards in the 
research. Collis and Hussey (2014) compiled a list of ethical principles for 
researchers:   
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 Harm to participants – potential harm from conducting the research should be 
avoided by ensuring the physical and psychological wellbeing of everyone 
involved.   
 Dignity – dignity should be respected for everyone involved and discomfort 
and anxiety should be avoided at all costs. 
 Informed consent – every research participant should provide fully informed 
consent.   
 Privacy – research participants’ privacy should be protected and invasion of 
privacy should be avoided at all costs.   
 Confidentiality – confidentiality should be ensured of everyone involved.   
 Anonymity – protecting research participants’ anonymity.   
 Deception – the possibility of deception during the research process, through 
lies or misleading behaviour should be guarded.   
 Affiliation – declare any personal or professional affiliation that may impact the 
research, as well as any conflict of interest, sponsorship or sources of 
research funding.   
 Honesty and transparency – be honest and open in communicating 
information about the research to all involved.   
 Reciprocity – the researcher and participants should gain mutual benefit out of 
the research.   
 Miss-representation – the need to avoid deception, misunderstanding, miss-
representing or incorrectly reporting the research findings (Collis and Hussey, 
2014).  
 
To this end an ethical clearance form (Form E) was completed and may be reviewed 
in Appendix B.   
 
The research protocol was divided into three main sections (see Appendix C): 
 
Section A:  Healthcare professional perception of a product 
This section was intended to uncover the importance of a manufacturing company 
and to understand the key reasons for prescription. At no point was any identifying 
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data collected regarding the healthcare professional or the brand of a product.  
Section A answered research sub-questions one, two and three. 
 
Section B:  Healthcare perception of a medical representative 
This section was used to comprehend the function, importance and worth that a 
medical representative adds to the healthcare professionals practice. Section B 
answered research sub-question four. 
 
Section C:  Healthcare professional decision-making process 
This section briefly determined where healthcare professionals currently receive and 
prefer to receive information regarding products, as well as analysed prescription 
behaviour.  Section C answered research sub-question five and six. 
 
The research protocol measured information in both nominal and interval variables.  
Statements varied from a five-point Likert scale with responses ranging from not 
important at all (1), to extremely important (5), as well as open ended questions. The 
researcher aimed to collect the most amount possible, in depth and thorough 
information through varies types of structured questions in the interviews. The 
researcher adapted her style with each interview to fit the specific respondent’s 
personality. All interviews were audio recorded with the permission of the respondent 
to make optimal usage of time. 
 
3.6  RELIABILITY AND VALIDITY 
 
Reliability refers to the absence of differences in the results if the research were 
repeated, while validity is the extent to which the research findings correctly reflect 
the phenomena under the study (Arnolds, 2014; Collis and Hussey, 2014). 
 
3.6.1  Reliability 
 
Reliability is concerned with the correctness of the information obtained and the 
more reliable the data, the more likely it is that duplicate experiments will produce 
similar results (Collis and Hussey, 2014).  
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Reliability can be measured multiple ways depending on the type of instrument.  The 
most common forms include: (a) test-retest (comparing item responses from same 
participants at different time points), (b) internal consistency (comparing item 
responses against other item responses), and (c) scorer reliability (comparing one 
reviewer with another reviewer—in case a scorer is completing the instrument). 
If reliable, researchers can assume the instrument’s scores are dependable, 
consistent, and more likely to be generalized to other samples, times, reviewers, and 
samples of behaviors.  Validity cannot exist without reliability (Hagan, 2014).   
 
3.6.2  Validity 
 
Validity “refers to the extent to which a test measures what the researcher wants it to 
measure and the results reflect the phenomena under study.  Research errors, such 
as faulty procedures, poor samples and inaccurate or misleading measurement, can 
undermine validity,” (Collis and Hussey, 2014. p.53). There are several different 
types of validity, according to Collis and Hussey (2014. p.53).  These types are: 
 
 Face validity:  Ensures that the test measures what is was meant to on a 
superficial level. 
 Construct validity: Includes behaviour that hypothetical constructs cannot 
measure (e.g. motivation, satisfaction and anxiety) but are important 
observations in behaviour. 
 Content validity: Guarantees that the content involves a representative sample 
of the phenomenon to be measured (Collis and Hussey, 2014; Hagan, 2014).   
 
The researcher ensured face, construct and content validity by conducting a 
thorough literature review, interacting with healthcare professionals and basing the 
interview protocol on previously validated questionnaires and surveys.   
 (Hagan, 2014).   
 
The most important quality control issue in research is the validity of a study and its 
findings. A valid study is one that has correctly collected and interpreted its data, so 
that the conclusions truthfully reflect and represent the real world that was studied 
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(Yin, 2011).  The researcher compiled the raw data on a Microsoft Excel 
spreadsheet and analysed the data used for developing a marketing framework to 
enhance healthcare professionals' prescription for specialised infant formula. The 
researcher made use of seven steps, listed in Yin (2011) to validate this study. 
These seven strategies for combating threats to validity in quantitative research are: 
 
1. Intensive long-term [field] involvement - to be able to understand the true 
situation and be able to make acute observations. 
2. Rich data - to have the potential to cover the observations and interviews 
completely with thorough and diverse data. 
3. Respondent validation - to obtain feedback from the respondents under study, 
to reduce the misinterpretations of self-reported views, opinions and 
behaviours.   
4. Search for discrepant evidence and negative cases - to test for contradicting 
explanations.   
5. Triangulation - to accumulate converging evidence from diverse sources. 
6. Quasi-statistics - to use real numbers in place of adjectives. 
7. Comparison - to compare the results openly across different settings, groups, 
or individuals (Yin, 2011. p.244-245). 
 
3.7 PROCEDURE FOR DATA COLLECTION 
 
Data serves as the groundwork for a research study. In quantitative research, the 
data are collected and recorded systematically, and these are then organised so that 
they can be entered into a computer database.  There are a variety of techniques 
that can be used to collect data in a quantitative research study.  However, all of 
them are geared towards numerical collection.  This numerical data can be collected 
by means of:  observation,  interview,  questionnaires, scales and physiological 
measurement. 
 
Special attention is drawn to conducting interviews.  Interviews are a method of data 
collection in which participants are asked questions to determine what they do, think 
or feel. Verbal or visual prompts may be required.  Under a positivistic paradigm, 
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interviews are concerned with exploring data related to understandings, opinions, 
what people remember doing, attitudes and behaviour that respondents have in 
common (Yin, 2011).  A variety of methods exist for the administration of interviews. 
Face-to-face, telephone or online interviews are described concisely in Collis and 
Hussey (2014). 
 
The researcher made use of the face-to-face interview method. The interviews were 
analysed and transcribed afterwards to make comprehensive interpretations. This 
method offers an advantage as comprehensive data can be collected and this may 
be useful if you need to ask complex or sensitive questions.  This method is 
inexpensive and more time consuming than most others. This process resulted in the 
collection of primary data for analysis (Collis and Hussey, 2014).   
 
To improve validity, a summary can be sent back afterwards to some of the 
interviewees for feedback on the researcher’s interpretation (Collis and Hussey, 
2014). To improve validity in this study, a summary was sent back to five of the 
interviewees for feedback on the researcher’s interpretation (Collis and Hussey, 
2014). All of the responses were returned with no changes required, thus illustrating 
validity and reliability of the researcher’s interpretation of the interviews as 100 
percent (100%).    
 
3.8  RESPONSE RATE 
 
An effort was made to reach all 63 potential respondents in Port Elizabeth but this 
proved logistically problematic. Appointments were made, but could not always be 
carried through due to healthcare professionals’ responsibility to their profession.  
The interview and response rate for this study is shown in Table 3.4. 
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Table 3.4: Response rate of respondents in Port Elizabeth 
 
Possible 
Interviewees 
Actual 
Interviewees  
Response rate Comment  
63 39 61.9% Healthcare 
professionals’ 
responsibility to 
their profession 
Source: (Author’s own construction based on respondents) 
 
3.9  DATA ANALYSIS AND INTERPRETATION 
 
The relationships between prescription (dependent variable) and its proposed 
determinants (independent variables mentioned previously) were analysed. 
Descriptive statistics were conducted by the researcher to summarise the data in a 
more condensed form and it is represented in charts, tables and graphs for easier 
assimilation and digestion (Collis and Hussey, 2014).  This form of analysis was 
used to look for patterns in the responses that were not immediately seen in the raw 
data.   
 
3.10  SUMMARY 
 
This chapter dealt with the process undertaken to comprehensively ensure that the 
research methodology was effective and accurate. The chapter expanded on the 
research type, the research paradigm, sampling method and data collection. The 
quantitative approach was used to interview HCPs using a research instrument 
constructed from themes identified in the literature reviewed. The empirical results 
were used to provide insight into drivers that were of significance to HCPs and to test 
the relationship of variable themes regarding the prescription of specialised IF. This 
chapter also discussed the methods used to do this, along with the proposed 
approach to ensure both the reliability and validity of the data received. The following 
chapter outlines the empirical results obtained from the research instrument from 
both a descriptive and analysis perspective. 
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Chapter 4 
RESEARCH RESULTS AND ANALYSIS 
 
4.1  INTRODUCTION 
 
The previous chapter served as an outline of the research methodology employed to 
test the relationships between the key drivers and the healthcare professional 
prescriptions. The data collected also served as a useful window to understand the 
healthcare professional’s reasoning for prescribing a specific specialised infant 
formula.  
 
In Chapter 4 the data is presented by making use of descriptive statistics in the form 
of graphs, tables and charts.  Chapter 4 will reflect a consolidation of the results from 
the conducted survey to give credibility to the literature reviewed regarding the 
phenomena under study.  The results from the interviews are summarised under 
three main categories as reflected below: 
 
 Section A – Healthcare professional perception of a product. 
 Section B – Healthcare professional perception of a medical representative. 
 Section C – Healthcare professional decision-making process. 
 
4.2  RESPONSE RATE ANALYSIS 
 
Healthcare professionals working with paediatric patients in Port Elizabeth were 
interviewed for this study.  The researcher had access to 63 healthcare professionals 
by making use of a medical representative data base.  The interviews were 
conducted in a face-to-face manner in the month of September 2015.  The 
researcher made appointments with various HCPs and managed to interview 39 
HCPs, consisting of paediatricians working in the private sector, dieticians working 
both in the state and private sectors and nurses practicing in private baby clinics. 
This is displayed in Table 4.1.   
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Table 4.1: Potential respondents from healthcare professionals scripting specialised 
infant formula in Port Elizabeth  
 
Respondent type Frequency of response Percentage (%) 
Paediatrician 5       12.8 
Dietician 17     43.6 
Private Nurse 17     43.6 
TOTAL 39     100 
Source: (Author’s own construction from empirical data) 
 
 
Chart 4.1: HCP participation  
 
It was difficult to interview the paediatricians because of availability. The researcher 
made appointments, but the paediatricians were not always able to abide with this 
due to patient responsibility or did not have 10 minutes to spare for the interview. 
The nurses and dieticians were easier to gain access to and the researcher could 
interview them for longer periods of time.   
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4.3  PRESENTATION AND DATA ANALYSIS  
 
4.3.1  Section A: Healthcare professionals’ perception of a product 
 
The questions in Section A aimed to determine the healthcare professionals’ 
perception of a product by assessing the importance of three independent variables: 
the manufacturing company, product composition and cost of product. The 
researcher made use of a Likert scale to determine the importance of a 
manufacturing company and scientific trials completed on a product. The categories 
were as follows: 
 
 5 – Very important. 
 4 – Important. 
 3 – Uncertain. 
 2 – Not important. 
 1 – Not important at all.   
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Question 1: How important is the credibility of a manufacturing company to a 
healthcare professional’s perception of a product? 
 
 
Chart 4.2:  Importance of the credibility of a manufacturing company  
 
Chart 4.2 illustrates clearly that the credibility of a manufacturing company is very 
important for sixty four percent (n=25) of the respondents. Eighty two percent (n=14) 
of the dieticians and fifty three percent (n=9) of nurses rate the credibility of a 
manufacturing company as very important on the Likert scale. Forty percent of the 
paediatricians (n=2) rate the credibility of a manufacturing company as very 
important as well as just important. It is evident that the credibility of a manufacturing 
company is of utmost importance for all three professions. 
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Question 2: How important is the scientific testing done on a product to a 
healthcare professional? 
Chart 4.3: Importance of scientific trials done on a product  
Scientific trials are very important to sixty seven percent (n=26) of healthcare 
professionals according to Chart 4.3, consisting of eighty two percent (n=14) of 
dieticians, sixty percent (n=3) of paediatricians and fifty three percent (n=9) of 
nurses.     
After a thorough analysis of the data, four key reasons emerged as important to a 
healthcare professional in prescribing a specialised infant formula. The four key 
reasons are:  trusted manufacturing company; composition of a product; efficacy of a 
product; and the price of a product. The researcher wanted to determine what the 
primary reason is, so therefore asked the healthcare professional to choose one. 
Question 3:  What is the key reason for prescribing a product to a healthcare 
professional? 
 Trusted manufacturing company. 
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 Composition of a product. 
 Efficacy of a product. 
 Price of a product. 
 
 
Chart 4.4: Dieticians’ key reason for prescribing a product  
Seventeen dieticians are included in this study, but two rated two reasons equally, 
therefore the amount of respondents is 19 (n=19) for this specific question. The 
results in Chart 4.4 illustrate that dieticians focus mainly on the composition of a 
product fifty three percent (n=10), followed by the efficacy of a product with forty two 
percent (n=8). Manufacturing company and price do not play such big roles in their 
perception of a product.  These results confirm the nature of dieticians to be 
scientifically orientated. 
5%
53%
42%
0%
Dieticians' key reasons for prescribing a 
product
Manufacturing Company
 Compositin of Product
 Efficacy of Product
 Price of Product
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Chart 4.5: Paediatricians’ key reasons for prescribing a product 
Five paediatricians are included in this study, but one rated two reasons as equally 
important. Therefore the amount of respondents is six (n=6) for this specific question.  
Chart 4.5 illustrates the key reasons for paediatricians, both equally the efficacy and 
price of a product at thirty three percent (n=2), followed by the manufacturing 
company and composition equally at seventeen percent (n=1). These results can 
mean that paediatricians are results focused, while attempting to keep the cost of 
healthcare down for parents.   
 
17%
17%
33%
33%
Paediatricians' key reasons for prescribing a 
product
Manufacturing Company
 Composition of Product
 Efficacy of Product
 Price of Product
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Chart 4.6: Nurses’ key reasons for prescribing a product 
Seventeen nurses are included in this study, but three rated more than one key 
reason.  Therefore the amount of respondents is 20 (n=20) for this specific question. 
Nurses prescribe a product predominantly for the efficacy thereof, with sixty five 
percent (n=13), according to Chart 4.6.  The other key reasons can be rated as 
manufacturing company at twenty percent (n=4), composition of a product at ten 
percent (n=2) and lastly price of a product at five percent (n=1).  Nurses are 
practically orientated as the results confirm a strong preference for the efficacy of a 
product. 
 
Chart 4.7: Healthcare professionals’ key reasons for prescribing a product 
20%
10%
65%
5%
Nurses' key reasons for prescribing a product
Manufacturing Company
 Composition of Product
 Efficacy of Product
 Price of Product
13%
29%
51%
7%
HCPs' key reasons for prescribing a product
Manufacturing Company
 Composition of Product
 Efficacy of Product
 Price of Product
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There are 45 respondents for this specific question because of the two dieticians, 
three nurses and one nurse who rated more than one key reason as equally 
important.  Chart 4.7 illustrates all of the respondents’ reasons, which are: in favour 
of efficacy of a product with fifty one percent (n=23), followed by composition of a 
product at twenty nine percent (n=13), manufacturing company thirteen percent 
(n=6) and price of a product seven percent (n=3). 
The word efficacy is described in the Oxford Dictionary as having the skill to 
ascertain a certain outcome or preferred result. The respondents, when prescribing a 
specialised infant formula, are clearly looking for a product that will give the desired 
results.   
 
4.3.2 Section B: Healthcare professionals’ perception of a medical 
representative 
Medical representatives are trained by manufacturing companies primarily to market 
a product in the most proficient way to healthcare professionals. This section aims to 
determine the healthcare professionals’ perception of a medical representative. 
Question 4: What is the healthcare professionals’ perception of the role of a 
medical representative? 
This question was asked as an open ended question. The healthcare professionals 
were very frank with their answers and it is clear that they have high expectations of 
medical representatives. The medical representative, represents the face of the 
manufacturing company and professional, scientific service are expected at all times 
from the healthcare professional. The feedback are listed below: 
Medical representative profile  
 Open, honest type of person. 
 Able to build professional relationship with healthcare professionals. 
 Trustworthy regarding quality of knowledge. 
 Clinical and practical orientated. 
 A medical education is an added bonus and increases credibility. 
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 Confident in self and sharing of information. 
 Accessible and available via telephone or email. 
 
Products orientated 
 Unbiased regarding products strengths and limitations. 
 Know products practical and clinical side.  
 Highlight what makes product different from competitors and reasoning 
behind difference / added advantage.  
 Need to have published scientific evidence regarding claims and benefits of 
products. 
 Know composition, macro- and micro-nutrients, of a product. 
 
Medical representative visits 
 Share new and relevant information at every visit. 
 Explain products in a practical manner, focus on results. 
 Share product information that is specific to healthcare professionals’ 
clientele. 
 Share peers opinions regarding products usage and experience. 
 Make sure healthcare professional feels comfortable / confident in prescribing 
specific product. 
 Visit should be concise in a short period of time.  
 Introduce new concepts.  
 Keep up to date regarding changes in products.  
 
Product issues 
 Sort supply-chain issues out. 
 Follow-up and keep to promises. 
 Customer service need to be very reliable.  
 React quickly and give feedback.  
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Question 5: Does the healthcare professional pay attention to the information 
relayed by the medical representative? 
 
Chart 4.8: Feedback of dieticians, paediatricians and nurses regarding paying 
attention to information relayed by the MR 
It is apparent according to Chart 4.8 that the respondents pay attention to the 
information relayed by the medical representative, with dieticians displaying one 
hundred percent (n=17), paediatricians eighty percent (n=4) and nurses sixty five 
percent (n=11).  Twenty percent of paediatricians (n=1) and thirty five percent (n=6) 
of nurses only sometimes pay attention to information relayed by the medical 
representative. None of the respondents stated ‘no’. 
 
 
 
 
 
 
 
 
 
 
100%
Dieticians
Yes  No  Sometime
80%
20%
Paediatricians
yes  no  sometimes
65%
35%
Nurses
Yes  No  Sometimes
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Question 6: What percentage of the information relayed by the medical 
representative does the healthcare professional remember? 
 
Chart 4.9: Percentage of information relayed by medical representative that 
healthcare professionals remembered  
Chart 4.9 illustrates very positive results for manufacturing companies. The majority 
of dieticians, paediatricians and nurses claim to remember between 71 – 80 percent 
(71 – 80%) of information relayed by the medical representative.   
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Question 7: Do healthcare professionals make decisions based on the 
information relayed by the medical representative? 
 
Chart 4.10: Decisions of dieticians, paediatricians and nurses based on information 
relayed by MR 
Dieticians are the most sceptical with fifty nine percent (n=10) being hesitant, forty 
percent (n=2) of paediatricians are hesitant and in contrast eighty two percent (n=14) 
of nurses’ decisions are based on information relayed by the medical 
representatives.   
Question 8: How much confidence do healthcare professionals have in the 
correctness of information relayed by the MR? 
 5 - Complete confidence. 
 4 - Confident. 
 3 - Uncertain. 
 2 - Not confident. 
 1 - Do not trust. 
41%
59%
0%
Dieticians
Yes  Hesitant  No
60%
40%
0%
Paediatricians
Yes  Hesitant  No
82%
18% 0%
Nurses
Yes  Hesitant  No
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Chart 4.11: Credibility rating of MR according to dieticians, paediatricians and 
nurses 
Chart 4.11 displays that nurses perceive medical representatives as the most 
credible with seventy six percent (n=13) having complete confidence. Dieticians are 
forty seven percent (n=8) confident and paediatricians are seventy five percent (n=3) 
uncertain regarding the credibility of medical representatives.    
 
4.3.3  Section C:  Healthcare professionals’ decision-making process 
 
Section C aimed to determine what form or source of information is important to 
healthcare professionals to make informed decisions. 
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Question 9: How often would healthcare professionals like to see a medical 
representative? 
 
Chart 4.12: How often dieticians want to be seen by MR  
The bulk of dieticians want to be seen every eight weeks - forty one percent (n=7), 
followed by every twelve weeks by twenty three percent (n=4), every fourth week by 
eighteen percent (n=3), every six weeks by twelve percent (n=2), and only when new 
information can be shared by six percent (n=1).   
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Chart 4.13: How often paediatricians want to be seen by MR 
Forty percent (n=2) wants to be seen every six weeks, and twenty percent (n=1) 
wants to be seen respectively every twenty four weeks, every twelve weeks or every 
four weeks.  
 
Chart 4.14: How often nurses want to be seen by MR 
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Thirty five percent (n=6) want to be seen every six weeks or every four weeks, 
twelve percent (n=2) every eight weeks or weekly, and six percent (n=1) want to be 
seen every six weeks. Nurses regard medical representatives as a valuable source 
of information in their practice. The regularity that they want to see a medical 
representative in Chart 4.14, the trust in information relayed by the medical 
representative in Chart 4.10 and the high credibility in Chart 4.11 can serve as 
confirmation of this assumption. 
 
Chart 4.15: How often a healthcare professional wants to be seen by a MR  
Chart 4.15 illustrates a colourful image of how often the respondents want to be seen 
by a medical representative.  Twenty six percent (n=10) every four weeks, twenty 
three percent (n=9) every eight weeks, fifteen percent (n=6) every two weeks, 
thirteen percent (n=5) every twelve or six weeks, five percent (n=2) every week and 
two and a half percent (n=1) only when new information can be shared or every 
twenty four weeks. 
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Question 10: How does the healthcare professional require the latest 
information on new specialised infant formula? 
 
 
 
Chart 4.16: Dieticians, paediatricians and nurses source of latest information 
regarding new specialised infant formula 
 
Three dieticians rated more than one source, therefore the number of dietician 
respondents is 20 (n=20); four paediatricians rated more than one source, therefore 
the number of respondents is nine (n=9); and three nurses rated more than one 
source, therefore the number of respondents is 20 (n=20). The total number of 
respondents for this specific question is 49 (n=49). 
Chart 4.16 illustrates clearly that dieticians, seventy percent (n=14) and nurses, 
eighty five percent (n=17), received their latest information regarding new specialised 
infant formula from a detailing session by a medical representative. The majority of 
paediatricians, forty five percent (n=4) received their latest information from a 
congress and thirty three percent (n=3) received latest information from a medical 
representative.   
 
0% 5%
85%
10%0%
Nurses
University  Peers
 MR  Congress
 Journals
11% 0%
33%
45%
11%
Paediatricians
University  Peers
 MR  Congress
 Journals
15%
15%
70%
0% 0%
Dieticians
University  Peers
 MR  Congress
 Journals
78 
 
 
Chart 4.17: Healthcare professionals’ source of latest information regarding new 
specialised infant formula 
The collided image of the respondents illustrate that seventy percent (n=34) obtain 
information from medical representatives, twelve percent (n=6) from congresses, 
eight percent (n=4) respectively from peers or university and two percent (n=1) from 
journals.   
Question 11: Where does the healthcare professional prefer to receive 
information regarding specialised infant formula? 
 
Chart 4.18: Preferred choice of source for dieticians, paediatricians and nurses to 
receive information regarding specialised infant formula 
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One dietician rated more than one source, therefore the number of dietician 
respondents is 18 (n=18); three paediatricians rated more than one source, therefore 
the number of respondents is eight (n=8); and seven nurses rated more than one 
source, therefore the number of respondents is 24 (n=24). The total number of 
respondents for this specific question is 50 (n=50). 
The following results are illustrated in Chart 4.18.  Seventy eight percent (n=14) of 
dieticians and sixty seven percent (n=16) of nurses prefer to receive information from 
a one-on-one detailing from a medical representative. This allows them to ask 
questions specific to their practice and patient conditions to the medical 
representative.  Fifty percent (n=4) of paediatricians prefer to receive information 
from congresses with an objective speaker.  Paediatricians feel this provides a 
product with more credibility. 
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Question 12:  What is the healthcare professionals’ main reason for 
prescribing the most recent specialised infant formula scripted? 
 
Chart 4.19: Dieticians’ key reason for recommending most recent specialised infant 
formula 
Nine dieticians rated more than one source, therefore the number of respondents is 
26 (n=26) for this specific question. As illustrated in Chart 4.19, thirty eight percent 
(n=10) of dieticians prescribe a specialised product because the product has been 
tried and tested.  This research included dieticians working in the state sector as 
well, which is why twenty seven percent (n=7) will prescribe a product if it is available 
and nineteen percent (n=5) will use trial and error of products until the results are 
positive.   
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Chart 4.20: Paediatricians’ key reason for recommending most recent specialised 
infant formula 
Chart 4.20 confirms clearly that paediatricians prescribe a product because it is tried 
and trusted as well as other reasons. The other reasons are journals or congresses. 
The tried and tested reason is confirmed by Chart 4.5 with efficacy of a product 
receiving a high rating. The importance of journals and congresses is confirmed by 
Chart 4.20 as congresses and journals are the preferred source of receiving 
information regarding specialised infant formula.   
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Chart 4.21: Nurses’ key reason for recommending most recent specialised infant 
formula 
Chart 4.21 displays how nurses are persuaded by medical representative to 
prescribe their products.  One nurse rated more than one reason, therefore the 
number of respondents is 18 (n=18) for this specific question.  Forty four percent 
(n=8) prescribe products because the medical representative convinced them, and 
thirty nine percent (n=7) because of products been tried and tested.  This chart just 
confirms again the importance of a medical representative to a nurse. 
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Chart 4.22: Healthcare professionals’ key reason for recommending most recent 
specialised infant formula 
The number of total respondents for this question is 49 (n=49) because of the nine 
dieticians and one nurse who rated more than one reason.  The concluded key 
reason for recommending a specialised infant formula is tried and tested by thirty 
nine percent (n=19), followed convinced by medical representative by twenty percent 
(n=10), as illustrated in Chart 4.22. 
These results are significant to manufacturing companies that have been in the 
market for some time and are threatened by competitors wanting to enter the market.  
It is comforting to conclude that healthcare professionals’ key reason for prescribing 
is because of the efficacy of a product (Chart 4.7) and tried and tested (Chart 4.24). 
 
4.4  Findings and interpretations of hypotheses 
 
4.4.1  Manufacturing company 
 
The following question was posed as the first research question: How important is 
the credibility of a manufacturing company to a healthcare professional’s perception 
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of a product? The healthcare professionals were asked to rate the importance of the 
credibility of a manufacturing company on a Likert scale.     
  
Sixty four percent (64%) of healthcare professionals rated the credibility of the 
manufacturing company as extremely important, illustrated in Chart 4.2.  This rating 
provides proof that the credibility of a manufacturing company is extremely important 
for healthcare professionals.   
 
Published scientific trials increase the credibility of a manufacturing company. This is 
evident as sixty seven percent (67%) of respondents rate scientific trials done on 
products as extremely important, as illustrated in Chart 4.3. 
 
The researcher rejects H01 that manufacturing companies exert no influence on 
prescribing habits.  Manufacturing companies do exert an influence on prescribing 
behaviour of healthcare professionals. 
 
4.4.2  Product efficacy 
 
Product efficacy is concluded as the key reason for prescribing specialised infant 
formula for healthcare professionals, as already discussed above in Section 5.3.3. 
The word ‘efficacy’ described in the Oxford Dictionary as having the skill to ascertain 
a certain outcome or preferred result, hints that these healthcare professionals have 
used the product before with satisfactory results. This assumption can be confirmed 
with Chart 4.24 illustrating ‘tried and trusted’ as the highest reason for scripting the 
latest specialised infant formula.    
 
The researcher rejects H02 that product efficacy exerts no influence on prescribing 
habits of healthcare professionals. Product efficacy is the primary reason for 
healthcare professionals to prescribe a specialised infant formula.   
 
4.4.3  Cost of product 
 
Cost of a product is one of the most important market-related issues when analysing 
purchasing behaviour of consumer goods (Sanlier and Karakus, 2010).  This 
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research revealed that healthcare professionals consider cost as a secondary factor 
in their decision-making process of prescribing a specialised infant formula.  
 
The researcher rejects the H03 hypothesis that cost of product exerts no influence on 
prescribing habits, because costs are a primary factor for paediatricians. Dieticians 
and nurses also confess if the efficacy and composition of a product is exactly the 
same, then costs will be the deciding factor.   
 
4.4.4  Medical representative 
 
The medical nutrition industry makes use of medical representatives to market their 
products.  The role of a medical representative is to detail the features and benefits 
of a specific product to a healthcare professional with the aim of persuading the 
healthcare professional to recommend the product to parents. Fortunately for 
manufacturing companies, the results of this study illustrate that medical 
representatives play a fundamental role in the decision-making process of healthcare 
professionals.  Question five in the protocol asked healthcare professionals if they 
paid attention to information relayed by the medical representative. The answers are 
displayed in Table 4.2.  
 
Table 4.2: Respondents pay attention to information relayed by the medical 
representative 
 
 Yes Sometime No 
Dieticians 100% 0% 0% 
Paediatricians 80% 20% 0% 
Nurses 65% 35% 0% 
 
Question six is a follow up question to question five and asked healthcare 
professionals the percentage of information they remember, relayed by the medical 
representative. The majority of respondents claim to remember between 71 – 80 
percent of information relayed by the medical representative which was illustrated in 
Chart 4.9. 
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Question seven determined if healthcare professionals made decisions based on 
information relayed by the medical representative and the results are displayed in 
Table 4.3. 
 
Table 4.3: Respondents decisions based on information relayed by medical 
representative 
 
 Yes Hesitant No 
Dieticians 41% 59% 0% 
Paediatricians 60% 40% 0% 
Nurses 82% 18% 0% 
 
Nurses and paediatricians trust medical representatives, but dieticians are true to 
their nature, which is hesitant.   
 
Question seven aimed to determine the confidence a healthcare professional has in 
the correctness of information relayed by the medical representative. These results 
were displayed in Chart 4.11. Nurses have complete confidence in the credibility and 
correctness of information relayed by the medical representative. Dieticians feel 
confident in the correctness of information relayed by the medical representative, but 
their confidence will increase if the medical representative can back this information 
with a scientific reference. Paediatricians are uncertain regarding the correctness of 
information relayed by the medical representative. This is a very strong statement 
and can be confirmed by Chart 4.20 which illustrated that paediatricians prefer to 
receive information from congresses or journals. Dieticians and nurses prefer to 
receive information from a one-on-one detailing session with a medical 
representative. This allows them to ask questions specific to their practice and 
patient conditions.   
 
The H04 hypothesis is therefore rejected, that the medical representative has no 
influence on prescribing habits of healthcare professionals.   
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4.4.5 Peers of healthcare professional 
 
The role of peers influencing and shaping prescriber opinions and behaviour has 
been studied by Maynor (2010). An unexpected element is the prevalence of 
informal influence and support networks that provide accessible and trusted 
information to healthcare professionals in everyday practice.  Peer-led meetings are 
becoming an increasingly important part of healthcare professionals’ information 
sources. Marketers thus need to understand how influential peers fit into an overall 
communications mix and how best to leverage peer influence in mounting effective 
local meetings and events (Maynor, 2010).   
 
The results of this research contradict the fact that peers, according to previous 
research, play a big role in the decision-making process of the respondents. Only the 
dieticians regarded peers as an important source of information. Therefore, disparity 
with research done by Maynor (2010) means that Ho5 hypothesis is not rejected.  
Peers do not have an influence on the prescribing habits of healthcare professionals, 
interviewed for this study. 
 
4.5  SUMMARY 
The interpretation and analysis of the questionnaire was completed using thematic 
analysis methods and Microsoft Excel.  The empirical interview results were 
substantiated with the interpretive findings which were in the form of verbatim 
statements extracted directly from the research questionnaire.   
Section A was interpreted using histogram and pie charts for analysis.  Section B 
was interpreted using doughnut, histogram and pie charts to display findings.  
Section C was interpreted by using a combination of bar, histogram and pie charts. 
This interpretation allows the interpretation of scores from the respondents which are 
presented in percentage format.  What stood out as significant in the findings are the 
difference in healthcare professionals’ perception of medical representatives, the 
format in which they prefer to receive information and their key reasons for 
prescribing a specific formula. These differences and the business impact thereof 
are discussed further in Chapter 5. 
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Chapter 5 
SUMMARY OF THE ANALYSIS, CONCLUSION AND 
RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
Chapter 4 presented and analysed the results of the empirical study about the 
prescription of specialised IF by healthcare professionals. Through the use of 
descriptive statistics, analyses were drawn about the types of healthcare 
professionals included in the study, the correlation between independent prescription 
variables and the dependable prescription drivers of healthcare professionals.  
Descriptive statistics analysis allowed a deeper understanding of the perception 
behaviour of respondents and also brought further areas of interest to the surface.  
This allowed the development of a marketing framework to enhance healthcare 
professionals’ prescription for specialised infant formula. The marketing framework 
can be seen in Appendix D. 
 
This final chapter will start by addressing the study’s stated sub-questions in light of 
what has been learned through the completion of this research work. The broader 
meanings behind the results are then discussed as recommendations.  This study 
can provide guidance to manufacturing companies with the focus of developing 
products for specialised conditions and allow them to devise product development 
and marketing strategies to enhance their competitive advantage.   
 
5.2  OVERVIEW OF THE LITERATURE 
 
The approach to the literature review followed a chronological assessment of the 
marketing of infant formula.  The introduction focused on the regulations of 
marketing infant formula, followed by a brief analysis of the major competitors of 
specialised infant formula in South Africa. The last section of the literature review 
dealt with the personal selling approach of medical representatives.  Although 
sufficient literature of regulations related to the marketing of infant formula as well as 
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personal selling techniques were available, the literature on personal selling with 
specific focus on the prescribing behaviour of specialised infant formula were limited.   
 
In order to address the main question as well as the sub-questions, three 
assessment criteria as reflected in Figure 5.1 were identified as means to 
contextualise and interpret the empirical results and findings. 
 
Figure 5.1:  Assessment criteria compiled by the author 
 
 
5.3  SUMMARY OF THE FINDINGS 
 
The study began with the main objective of developing the marketing framework that 
was demonstrated in the preceding chapters. To achieve this, use was made of sub-
questions which were addressed during the completion of both the literature review 
and the empirical research. Evaluation of the success of the study depends on the 
provision of the desired marketing framework as well as the degree to which these 
research questions have been sufficiently answered.   
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5.3.1  What are the key factors influencing healthcare professionals’ 
prescribing behaviour according to relevant literature?     
 
The key factors influencing healthcare professionals’ prescribing behaviour were 
explored in Chapter 1. The medical nutrition industry needs to abide by the 
European Society for Paediatric Gastroenterology Hepatology and Nutrition 
(ESPGHAN) guidelines for product development.  Medical nutrition companies 
translate the science of nutrition, through food and ingredient technology to generate 
innovative impactful products of high quality, stability, safety and value for 
consumers (Weenen, et al., 2013).    
 
Medical nutrition companies aspire to understand the reasoning behind the 
prescription behaviour of HCPs. Section 1.2 provided background to the study and 
Koletzko, et al. (2005) revealed that a HCP will prescribe a product if it is 
manufactured from a reputable company; abides by ESPGHAN guidelines; is tested 
in trials and the results have been published in trusted scientific sources; is locally 
available; is cost effective and the right product for the specific individual (Koletzko, 
et al., 2005). 
 
Chapter 2 highlighted in Section 2.5.1 the conditions that need to exist for an 
exchange to take place. These conditions require two or more individuals, groups or 
organisations to participate; each participant should hold something of value that the 
other party desires; both parties should trust the promise of ‘something of value’ held 
by the other; and expectations must be met from both sides for successful future 
transactions (Hult, et al., 2012). 
 
Section 2.6 explained the two forms of personal selling approaches, transactional 
and relational selling techniques. Both approaches have valuable characteristics that 
can be used interchangeably as an adaptive sales approach by the medical 
representative adapting to the encountered situation.  The adaptive sales approach 
has become the standard for implementing transactional selling and relational selling 
approaches. 
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5.3.2  Can the prescribing behaviour of healthcare professionals be 
measured, according to the literature? 
 
A measuring instrument to measure the prescribing behaviour of healthcare 
professionals could not be found in the literature reviewed. A few studies have 
examined cognitive processes used by healthcare professionals when making 
prescription choices. These studies generally examined factors which influence 
healthcare professionals when prescribing products.  In these studies the healthcare 
professionals were presented with case scenarios or common illnesses and 
instructed to describe (via interview or questionnaire) what products would be 
prescribed and the reasoning thereof.  This is also the reason the researcher 
decided to focus on cow’s milk protein allergy and follow the methodology of 
interviewing applicable healthcare professionals.    
 
A narrative study conducted by Baysari, Westbrook, Braithwaite and O’Day (2011. 
p.293) asserts that physicians appear to select drugs based on two main criteria: 
“the probability that the drug will be effective in controlling the disease (efficacy); and 
the probability that adverse effects will result from using the drug (safety).” Other 
factors such as drug cost, patient demand and hospital policy can also be influential, 
but are usually deciding factors when alternative drugs are considered to be 
equivalent with respect to efficacy and safety (Baysari, et al., 2011). 
 
The findings of this research, portrayed in Chapter 4, correlates with the findings of 
Baysari, et al. (2011). Section 4.3, Chart 4.7 exhibited that fifty one percent (51%) of 
respondents’ foremost reason for prescribing a specialised infant formula is efficacy 
of a product.   
 
5.3.3  What are the key factors regarding a product that will persuade a 
healthcare professional to prescribe the product? 
 
The researcher posed question three in the protocol to healthcare professionals to 
determine the key reasons for prescribing a product. This question aspired to 
determine the respondents’ primary reason for prescribing a specialised infant 
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formula.  The researcher narrowed the reasons down to four key factors, which are:  
trusted manufacturing company; composition of a product; efficacy of a product; and 
price of a product. The healthcare professional was requested to choose one.  More 
respondents, fifty one percent (51%) rated efficacy as the key reason, as illustrated 
in Chart 4.7.  The word efficacy is described in the Oxford Dictionary as having the 
skill to ascertain a certain outcome or preferred result, as explained in Section 4.3 in 
Chapter 4.    
 
The nutritional composition of all infant formulas must meet the global standards as 
recommended by ESPGHAN.  All infant formulas must contain sufficient amounts of 
basic nutrients, and are thus nutritionally interchangeable. Owens, et al. (2012) 
conclude in their research that no evidence exists to recommend one brand over 
another (Owens, et al., 2012). This brings the research back to the main problem: 
why do healthcare professionals prescribe one formula above another, if all are 
essentially the same?  Table 5.1 illustrates the combined results of question three in 
the protocol. 
 
Table 5.1: Main reasons of dieticians, paediatrician and nurses for prescribing a 
specialised infant formula 
 
 Trusted 
manufacturing 
company 
Composition of 
a product 
 
Efficacy of 
a product 
 
Price of a 
product 
 
Total 
Dietician 5% 53% 42% 0% 100% 
Paediatrician 17% 17% 33% 33% 100% 
Nurse 20% 10% 65% 5% 100% 
HCP 13% 29% 51% 7% 100% 
Source: (Compiled by author) 
 
The results in this study revealed that efficacy of a product is the primary reason for 
prescribing a specialised formula.  The researcher probed the interviewees to 
explain their reasoning if all products are essentially the same, as stated above by 
Owens, et al. (2012), would they not also produce the same results? Dieticians 
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responded by profiling the specific patient’s needs first and then comparing various 
brands to see which fits the patient profile the best. The products do have small 
differences in composition, such as additives, fatty acids (medium-chain-
triglycerides, alpha-linolenic acid, and docosahexaenoic acid) or nucleotides that will 
provide benefit for the specific patient condition.  This also explains why composition 
of a product is rated the highest for dieticians.  If there is not a significant difference 
in composition of the one product above the other, then price of product will be the 
deciding factor.  That makes price a secondary reason for choosing the specific 
product. 
 
The paediatricians’ rated efficacy and price of a product both at thirty three percent 
(33%). The paediatricians revealed that they prescribe the product they have 
experienced positive results with. Parents tend to be indecisive regarding products 
and experiment with various brands. Healthcare professionals call this: ‘product 
hopping’.  An infant’s gastro-intestinal track takes at least two weeks to adapt to a 
new formula, therefore product hopping is not good for infants. Paediatricians prefer 
products that they have had good results with, and will prevent parents from product 
hopping. A child can be on an excellent formula with exceptional results, but if the 
parents cannot afford the product, then there is no use. Therefore, the ‘price of 
product’ is also a relevant factor to take into consideration. This makes efficacy and 
price the primary reasons, and manufacturing company and composition of product 
the secondary reasons for paediatricians’ prescription. 
 
Nurses are practically orientated with sixty five percent (65%) rating efficacy of a 
product as the key reason. Efficacy is the primary reason and manufacturing 
company, price and composition of products are secondary reasons for nurses’ 
prescription. 
 
5.3.4 How can a medical representative add maximum value to a healthcare 
professional’s practice?  
 
Healthcare professionals have clear expectations of medical representatives. These 
expectations are listed in Section 4.3.2 under question four of the protocol.  A 
medical representative needs to have a medical background, be clinical and 
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practically inclined, easily assessable, open, honest and easy to communicate with. 
A medical representative should be able to incorporate the techniques of relationship 
and transactional selling as needed and required by the specific situation.  This is 
covered in depth in Chapter 2 under Section 2.6. 
 
5.3.5 What does the literature reveal as the main factors that influence the 
end consumer with regards to purchasing the product? 
 
Literature revealed that criteria such as taste, nutritional value, reliability, quality, 
price and convenience of the product are important for consumers. Consumers 
prefer to shop at supermarkets due to the consistency of the products sold, the 
ambiance and convenient personal inspection which are allowed in stores. 
Purchasing is the most important stage of providing safe products for the home. 
When faced with too much variety and various product quality, the consumer may be 
indecisive about which of the products to purchase.  The taste, nutritional value, 
reliability and persuasiveness of the price are quite important when buying products 
(Sanlier and Karakus, 2010).  Two factors that affect the product choices of 
consumers are:    
 
1. Consumer-related factors include familiarity and habit, psychographics and 
demographics, sensory variables, social interactions and health 
considerations. 
2. Price, distribution and promotion are the most important market-related issues 
(Sanlier, 2012). 
 
5.3.6 Can a detailed research methodology be developed to test the 
hypothesised model, to facilitate understanding and to allow repetition 
of the study? 
 
The methodology of the study was explained in Chapter 3 of the treatise. After 
establishing the suitability of a quantitative approach, a research design was put into 
practice in combination with research planning that made use of a consistency matrix 
(See Appendix A for Consistency Matrix). Non-probability sampling (convenience 
sampling) was used to select HCPs, who dealt with paediatric patients, as 
95 
 
respondents for the interviews. A questionnaire was used as a guide for the 
interviews. The research instrument was constructed on a five-point Likert scale and 
comprised of statements, each relevant to the variables identified in Chapters 1 and 
2. Data was collected and analysed using specific measures, ensuring reliability and 
validity. Great effort was made to make certain that each step of the process was 
documented, verified and validated.  
 
5.4 RECOMMENDATIONS 
 
The research methodology made use of a mixture of means to certify that the 
information collected was both reliable and convincing.  Through the application of 
these means and the use of statistical tools, a detailing tool was developed. This is 
illustrated in Table 5.2.  The detailing tool can help a medical representative to 
prepare in advance for a detailing call.  The tool summarise how often different 
healthcare professionals want to be seen; what aspects should be focussed on; how 
supporting material, like an article should be used; how new information should be 
shared; and how competitor activity can be combated. This tool along with the 
empirical data collected from the research, allows the formulation of 
recommendations for the enhancing of prescription for specialised infant formula 
from healthcare professionals. These recommendations will be clarified using the 
model variables as points of departure.  
 
Table 5.2:  Medical representative detailing tool 
 
Medical Representative Detailing 
 Dietician Paediatrician Nurse 
Visit frequency 4 weeks 6 weeks 2 – 4 weeks 
Focus on 
following in a 
detailing call 
-Credibility of 
manufacturing 
company; 
-Composition of 
product; 
-Efficacy of 
-Credibility of 
manufacturing 
company; 
 
 
-Efficacy of 
-Credibility of 
manufacturing 
company; 
 
 
-Efficacy of 
96 
 
product; 
 
-Information needs 
to be relevant to 
clientele. 
product; 
- Price of product;  
-Information needs 
to be relevant to 
clientele. 
product; 
 
-Information needs 
to be relevant to 
clientele. 
Article under 
discussion 
Just  need a 
reference of article 
Need a hard copy 
of the article plus a 
short summary of 
main points in 
article. 
Explain article in a 
practical manner.  
Nurse does not 
need to see the 
hard copy of the 
article. 
New information Wants to hear 
about new 
products from the 
MR. 
Prefer to hear 
about new products 
at congresses or 
from journals. 
Wants to hear 
about new products 
from the MR. 
Fight competitor 
products 
By focussing on 
‘tried and trusted’ 
component of 
products currently 
using. 
By focussing on 
‘tried and trusted’ 
component of 
products currently 
using; or 
use journals as 
evidence for 
persuasion. 
MR needs to 
convince nurse by 
making use of 
practical examples. 
Source: (Compiled by author) 
 
It is important for MR to understand the nature of HCPs.  This study reveals how 
paediatricians, dieticians and nurses perceive things differently.  These various 
HCPs want to be treated differently and expect different treatment from a MR.  MR 
need to understand the characteristics of the different professions.  This will help the 
MR to adapt personal selling techniques accordingly.  Focused and strategic selling 
techniques will help MRs to get the right message across to the specific HCP to 
encourage optimal scripting of specialised infant formula.    
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5.5 MANAGEMENT CONTRIBUTION 
 
This study provides guidance to manufacturing companies that focus on developing 
products for specialised conditions and allows them to devise product development 
and marketing strategies to enhance their competitive advantage. Through these 
strategies manufacturing companies can: 
 
 Save money by focussing on the core features of efficacy in the development 
of specialised infant formula. 
 Focus on the key contributing features of product composition, therefore 
resulting in a higher quality product for the end consumer. 
 Save money by appointing suitable candidates as medical representatives. 
 Invest in training of medical representatives with the desired selling 
techniques. 
 Train medical representatives more effectively regarding medical products to 
add value to healthcare professionals’ practice.   
 
5.6 LIMITATIONS OF THE STUDY 
 
A study limitation describes a weakness or deficiency in the research (Collis and 
Hussey, 2014). The following are a few relevant limitations of the study.  It serves 
both as an acknowledgement of potential issues and as a soundboard to discuss 
recommendations for future research: 
 
 Sample size - An effort was made to achieve a sample size of over fifty but 
the final total was 39.  Although this still allows the use of both inferential and 
descriptive statistics and is considered adequate in relation to the variables 
chosen, a larger sample size would have further increased the validity of the 
study. 
 Measure instrument - inadequate time was available to advance the 
measuring instrument through repeated reliability testing and validation. 
 Sample bias - there was a higher response rate from nurses and dieticians.  
Although an effort was made to try and collect samples from paediatricians, it 
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proved exceedingly difficult to get adequate time to conduct the interview.  
Paediatricians’ time is limited and some could not offer 10 minutes to conduct 
the interview.   
 Longitudinal effects - as the study was limited in time it would have been 
helpful to implement a questionnaire for the end consumer, the parent, to 
verify relationships to the HCP, assumptions made by the health industry and 
to determine their key reasons for purchasing a specific IF.     
 
5.7 SUGGESTIONS FOR FUTURE RESEARCH 
 
Taking the previous section into consideration, the following are suggestions for 
future research into a similar topic: 
 
 Larger sample size - A larger sample size would increase the validity of the 
study.  Consider using HCPs from East London as well. 
 Conducting a study by focusing on products for a different condition.  
Comparing the results would be useful to determine the true reasons for 
prescription by HCPs. 
 Healthcare professionals’ prescription - more research is needed into the 
construct of prescription of specialised infant formula.  Academic sources on 
the subject are lacking and most often apply to the prescription of 
pharmaceutical drugs.   
 Longer time frame for completion of research - longitudinal studies will be 
helpful in increasing the validity of the work and in validating research 
instruments for future use in prescription by healthcare professionals. 
 Review of variables - specific variables such as cost of product and peers of 
healthcare professionals, may deserve further investigation as influential 
drivers. 
 Efficacy of product; medical representative and manufacturing company – 
these three variables emerged as the most significant influencers on 
prescribing behaviour of healthcare professionals and warrant further 
research. 
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5.8 CONCLUSION 
 
The objective of this research treatise was to develop a marketing framework to 
enhance healthcare professionals' prescription for specialised infant formula. This 
can be utilised by manufacturing companies to improve outcomes of marketing 
specialised infant formula to healthcare professionals. This framework is in Appendix 
D. 
 
A literature and empirical study facilitated the construction of this framework and also 
allowed analysis of the perceptions of healthcare professionals of a product and that 
of the medical representative. It also increased understanding of the decision-making 
process of the healthcare professional.   
 
The research revealed that prescription behaviour is an important construct; it can be 
measured in medical practices; it is correlated with positive business and medical 
outcomes; and manufacturing companies are able to exert influence over it through 
the identified variables.  Of these variables efficacy of a product, trusted 
manufacturing company and the medical representatives were found to have a direct 
and significant effect.  Healthcare professionals tend to prescribe a specialised infant 
formula if they have seen results and trust the outcome of the product. It is advisable 
for manufacturing companies to exert great effort before appointing a medical 
representative, to make sure that the right candidate represents the face of the 
company.   
 
A final summary of the research objectives, questions and deliverables are 
summarised in Table 5.3 
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Table 5.3:  Final summary of the research objectives, questions and deliverables 
 
Title: 
A marketing framework to enhance healthcare professionals' prescription for specialised 
infant formula. 
Main research problem: 
Research into the key drivers that enhance healthcare professionals’ prescription for infant 
formula is lacking. No specific marketing framework for enhancing healthcare 
professionals’ prescription for specialised infant formula products exists.  Manufacturing 
companies invest a lot of money developing their products, employ and train medical 
representatives and trust that this will be enough to persuade the healthcare professionals 
to recommend their products to parents.   
Thesis statement: 
A marketing framework for enhancing healthcare professionals’ prescription for 
specialised infant formula can be developed. This may be used to improve training of 
medical representatives, allow infant manufacturing companies to save money, and 
medical representatives can add more value to healthcare professionals’ practices. 
Research objective: 
To develop a marketing framework for enhancing healthcare professionals’ prescription for 
specialised formula. 
Main Research Question (RQM): 
Can a marketing model be developed for enhancing healthcare professionals’ prescribing 
for specialised infant formula? 
Secondary research 
questions 
Research 
objective 
Chapter Deliverable / 
Research 
Objective 
RQ1 What is 
specialised infant 
formula, why do 
medical 
representatives 
market it, and 
what are the key 
factors 
influencing 
healthcare 
professionals 
prescribing 
behaviour?   
To define 
specialised infant 
formula, state 
medical 
representatives’ 
importance in the 
marketing strategy 
and discover 
healthcare 
professionals’ key 
drivers. 
Chapter 2:  
Literature study. 
RO1 Define 
specialised infant 
formula, state 
medical 
representatives’ 
role in marketing 
strategy and 
discover 
healthcare 
professionals’ key 
drivers. 
RQ2 How can the 
prescribing 
behaviour of 
healthcare 
professionals be 
measured? 
To review methods 
for prescribing 
behaviour.  
Chapter 3:  
Methodology of the 
study. 
RO2 To review 
methods to 
measure 
healthcare 
professional 
prescription. 
RQ3 Can the literature 
be used to 
develop a model 
for healthcare 
professionals’ 
prescription?   
To develop a 
hypothesised 
model for 
healthcare 
professionals’ 
prescription.  
Chapter 1: 
Proposal 
RO3 To develop a 
hypothesised 
model for 
healthcare 
professionals’ 
prescription for 
specialised infant 
formula.   
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RQ4 How can a 
detailed research 
methodology be 
developed to test 
the hypothesised 
model, to 
facilitate 
understanding 
and to allow 
repetition of the 
study? 
Explain the 
research 
methodology used 
for this research 
study in detail. 
Chapter 3: 
Methodology of the 
study. 
 
RO4 Research 
design.  A 
detailed 
description of the 
research 
methodology 
used to conduct 
this specific 
research project. 
RQ5 What results are 
obtained from the 
empirical study 
and how can they 
be interpreted? 
Conduct an 
analysis of the 
results and 
interpret them. 
Chapter 4: 
Research results 
and analysis. 
RO5 Results and 
interpretation of 
empirical results. 
RQN What conclusions 
and 
recommendations 
can be derived 
from the study 
and applied to 
enhance 
healthcare 
professionals’ 
prescription for 
specialised infant 
formula. 
Draw conclusions 
and offer 
recommendations 
from the study. 
Chapter 5: 
Findings, 
conclusions and 
recommendations. 
RON Conclusions 
and 
recommendation 
from the study, 
including ways to 
improve the 
healthcare 
professionals’ 
prescription for 
specialised infant 
formula. 
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APPENDIX C: FRAMEWORK FOR QUESTIONNAIRE 
SECTION A:  HCP PERCEPTION OF A PRODUCT 
Question 1:  How important is the credibility of a manufacturing company to a 
healthcare professional’s perception of a product? 
 5 – very important 
 4 – important 
 3 – uncertain  
 2 – not important 
 1 – not important at all   
Question 2:  How important is the scientific testing done on a product to a healthcare 
professional? 
 5 – very important 
 4 – important 
 3 – uncertain  
 2 – not important 
 1 – not important at all   
Question 3:  What is the key reason for prescribing a product to a healthcare 
professional? 
 Trusted manufacturing company 
 Composition of a product 
 Efficacy of a product 
 Price of a product 
 
SECTION B:  HEALTHCARE PROFESSIONAL PERCEPTION OF A MEDICAL 
REPRESENTATIVE 
Question 4: What is the healthcare professionals’ perception of the role of a medical 
representative? 
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Question 5:  Does the healthcare professional pay attention to the information 
relayed by the medical representative? 
Question 6:  What percentage of the information relayed by the medical 
representative does the healthcare professional remember? 
Question 7: Do healthcare professionals make decisions based on the information 
relayed by the medical representative? 
Question 8: How much confidence do healthcare professionals have in the 
correctness of information relayed by the MR? 
 5 - complete confidence 
 4- confident 
 3 – uncertain 
 2 – not confident 
 1 – do not trust 
SECTION C:  HEALTHCARE PROFESSIONAL DECISION-MAKING PROCESS  
Question 9: How often would healthcare professionals like to see a medical 
representative? 
 Weekly 
 Fortnightly 
 Monthly 
 Once every second month 
 Only when new information can be shared 
 
Question 10: How does the healthcare professional require the latest information on 
new specialised infant formula? 
 MR detailing one-on-one 
 Journal club sponsored by the medical nutrition company 
 Forum / Symposium sponsored by multiple companies 
 Congress 
 Peers 
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Question 11:  Where does the healthcare professional prefer to receive information 
regarding specialised infant formula? 
 Peers 
 MR 
 Medical / Scientific officers employed by companies 
 Correspondence from companies with scientific proof 
 Universities / Research faculties 
Question 12:  What is the healthcare professional’s main reason for prescribing the 
most recent specialised infant formula scripted? 
 The MR convinced me 
 The only name I remember 
 Tried and trusted 
 Cost effective 
 Journals / scientific evidence was convincing 
 Other 
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Annexure E:  Marketing Framework 
 
 
 
 
Marketing STP
Segmentation: 
Segment HCP’s according to importance to business
Select target Segment:  
Select specific HCP’s as target market for business objective
Positioning:
Creating and maintaining a certain concept of a product in 
customer’s mind
SWOT Analysis
Strength:  
Competitive advantage;  Core competencies
Weakness: 
Limitations;  Competitive disadvantage
Opportunities:
Favourable conditions in environment
Threats:
Barriers prevent company of reaching objectives
Business Objectives
Sustainable profit growth
Mareket Share
Sales growth
Awareness
Reputation
Response to customers
Risk containment
Innovation
Medical Representative Detailing 
 Dietician Paediatrician Sister 
Visit frequency 4 weeks 6 weeks 2 – 4 weeks 
Focus on following in call -Credibility of manufacturing company 
 
-Composition of product 
 
-Efficacy of product 
 
-Information need to be relevant to clientele 
-Credibility of manufacturing company 
 
-Efficacy of product 
 
 
- Price of product 
 
-Information need to be relevant to clientele 
-Credibility of manufacturing company 
 
-Efficacy of product 
 
-Information need to be relevant to clientele 
Articles Reference of article Hard copy + short summary Explain article 
New information MR need to inform Congress or Journals MR need to inform 
Fight competitor products Tried and trusted Tried and trusted 
Journals 
MR need to convince  
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